fibrinogen has been researched along with Diabetes Mellitus in 274 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 111 (40.51) | 18.7374 |
1990's | 50 (18.25) | 18.2507 |
2000's | 59 (21.53) | 29.6817 |
2010's | 38 (13.87) | 24.3611 |
2020's | 16 (5.84) | 2.80 |
Authors | Studies |
---|---|
Abell, T; Bills, G; Kedar, A; Pinkston, C; Rock, WA; Sarker, S; Seabrook, N | 1 |
Chen, L; Tan, HB; Zhao, Q | 1 |
Adaszek, Ł; Bochyńska, D; Lechowski, R; Milczak, A; Winiarczyk, D; Winiarczyk, M; Winiarczyk, S | 1 |
Gao, R; Jia, S; Li, T; Song, Y; Tang, X; Wang, P; Xu, B; Xu, J; Yang, Y; Yuan, D; Yuan, J; Zeng, G; Zhang, C; Zhao, X; Zhu, P | 1 |
Chen, D; Liu, J; Liu, P; Song, X; Zhang, Z; Zheng, L | 1 |
Harlow, SD; Karvonen-Gutierrez, CA; Lange-Maia, BS; Leis, AM; McConnell, DS; Sanders, WM; Ylitalo, KR | 1 |
Duan, M; Hellstrom, S; Karpeta, N; Li, C; Liu, J; Liu, Y; Peng, H; Tong, B; Xie, W | 1 |
Cai, Y; Dong, Z; Fu, W; He, H; Ju, S; Li, W; Li, X; Li, Y; Wang, G; Zhou, S | 1 |
Wang, X; Wei, H; Yang, C; Yang, Y; Zhang, T; Zhang, Y; Zhao, Q | 1 |
Belfiore, A; Cataldi, M; Di Lauro, T; Di Maro, M; Guida, B; Memoli, A; Santillo, M; Trio, R | 1 |
Jia, L; Jin, S; Li, X; Liu, F; Shan, C; Wang, J; Yang, Y; Zhang, Y | 1 |
Gao, Y; Han, M; Li, T; Li, X; Liu, Y; Wang, L; Wang, X; Wu, D; Xu, Y; Zhu, Y | 1 |
Dong, Q; Dong, QT; Gao, Y; Guo, YL; Li, JJ; Liu, SL; Shi, HW; Wu, NQ | 1 |
Chow, JH; Galvagno, S; Grazioli, A; Herr, D; Madathil, R; Mazzeffi, M; Menaker, J; Menne, A; Rabin, J; Scalea, T; Tabatabai, A; Tanaka, K | 1 |
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
Grammatikopoulou, MG; Hatziagorou, E; Kontouli, K; Spiliotis, BE; Tsanakas, J; Tsiroukidou, K; Tzimos, C; Vamvakis, A | 1 |
Gao, R; Gao, Z; Jia, S; Jiang, P; Liu, R; Liu, Y; Tang, X; Xu, B; Xu, J; Yang, Y; Yuan, D; Yuan, J; Zhang, C; Zhao, X; Zhu, P | 1 |
Bliden, KP; Cho, A; Gurbel, PA; Jerjian, C; Levy, JH; Rapista, N; Tantry, US; Walia, N | 1 |
Demchuk, AM; Hong, JM; Kang, DR; Lee, JS; Lee, SE; Lee, SJ; Ovbiagele, B | 1 |
Kieliszek, M; Lipinski, B | 1 |
Bray, GA; Goldberg, RB; Marcovina, SM; Mather, KJ; Orchard, TJ; Perreault, L; Temprosa, M | 1 |
Führer-Sakel, D; Hennig, F; Herder, C; Hoffmann, B; Jöckel, KH; Lucht, S; Moebus, S | 1 |
Bai, X; Li, R; Liu, J; Wang, L; Wu, Y; Xu, C; Yuan, Z; Zhang, L; Zhou, J | 1 |
de Mutsert, R; Lijfering, WM; Rosendaal, FR; van der Toorn, FA; van Hylckama Vlieg, A | 1 |
Chang, SJ; Ham, JH; Kim, DH; Kim, SH; Lee, JY; Lee, SS; Lim, EJ; Park, CI; Song, YK | 1 |
Baird, AE; Jackson, EA; Janket, SJ; Jones, JA; Meurman, JH; Surakka, M; Tao, W; Van Dyke, TE | 1 |
Ancelin, ML; Brailly-Tabard, S; Carcaillon, L; Dartigues, JF; Guiochon-Mantel, A; Rouaud, O; Scarabin, PY | 1 |
Dai, W; Li, Y; Lv, YN; Wei, CD; Zheng, HY | 1 |
Cohen, BE; Grenon, SM; Hiramoto, J; Smolderen, K; Vittinghoff, E; Whooley, MA | 1 |
Akkoyun, DC; Akyuz, A; Alpsoy, S; Erfan, G; Guzel, S; Kaya, S; Kulac, M; Topcu, B | 1 |
Freitas, IC; Lopes, DA; Moraes, SA | 1 |
Brite, J; Dowd, JB; McCrillis, AM; Reales, D; Romo, ML; Schooling, CM | 1 |
Bootzin, R; Carroll, JE; Irwin, MR; Melendez, G; Nicassio, P; Olmstead, R; Sadakane, R; Seeman, TE | 1 |
Aimaretti, G; Barbieri, L; Bellomo, G; De Luca, G; Di Giovine, G; Marino, P; Schaffer, A; Sinigaglia, F; Suryapranata, H; Verdoia, M | 1 |
Akalin, N; Akay, H; Erturk, K; Harmankaya, O; Kaptanogullari, H; Kocoglu, H; Okuturlar, Y | 1 |
Bhat, A; Dakna, M; Jankowski, V; Klein, J; Koeck, T; Mischak, H; Mullen, W; Nkuipou-Kenfack, E; Pich, A; Rudolph, KL; Schanstra, JP; Schumacher, B; Vlahou, A; Zürbig, P | 1 |
Efrati, O; Fisher, D; Forschmidt, R; Hemi, R; Kanety, H; Lavie, M; Modan-Moses, D; Sarouk, I; Vilozni, D | 1 |
Ma, A; Sun, S; Sun, Y; Zhang, X | 1 |
Kränkel, N; Landmesser, U; Rauch-Kroehnert, U; Steffens, D; Stratmann, B; Tabaraie, T; Tschoepe, D; Weithauser, A; Witkowski, M | 1 |
Cai, RW; Chen, YF; Huang, YH; Li, JJ; Li, MM; Lin, YY | 1 |
Rodger, M; Versteeg, HH | 1 |
Ajjan, R; Kearney, K; Smith, K; Tomlinson, D | 1 |
Bhatt, DL | 1 |
Aktoz, M; Ozcelik, F; Tatli, E | 1 |
Dzanković, F; Macić-Dzanković, A; Pojskić, B; Velija-Asimi, Z | 1 |
Alessi, MC; Cuisset, T; Dutour, A; Frère, C; Gaborit, B | 1 |
Collins, R; Danesh, J; Di Angelantonio, E; Kaptoge, S; Lowe, G; Pepys, MB; Thompson, SG | 1 |
Cushman, M; Diez-Roux, AV; Ranjit, N; Roy, B; Seeman, T; Shea, S | 1 |
Kafle, DR; Shrestha, P | 1 |
He, K; Jacobs, DR; Kim, DJ; Liu, K; Loria, C; Xun, P; Yokota, K | 1 |
Cao, H; Hotamisligil, GS; King, IB; Lemaitre, RN; Mozaffarian, D; Siscovick, DS; Song, X | 1 |
Babić, N; Dervisević, A; Huskić, J; Musić, M | 1 |
Wu, J; Zhang, J; Zhao, Y | 1 |
Ding, Y; Ji, X; Li, ZY; Meng, R; Meng, S; Wang, X | 1 |
Belson, L; Berthiaume, Y; Coderre, L; Malet, A; Rabasa-Lhoret, R; Tardif, A; Ziai, S | 1 |
Barac, A; Best, LG; Carter, EA; de Simone, G; Devereux, RB; Dixon, DB; Howard, BV; Panza, JA; Shara, NM; Umans, JG; Wang, H; Yeh, J | 1 |
Lipinski, B; Pretorius, E | 1 |
Batty, GD; Czernichow, S; Hamer, M; Kengne, AP; Stamatakis, E | 1 |
Menon, IS | 1 |
Andersen, RE; Crespo, CJ; Sempos, CT; Smit, E; Snelling, A | 1 |
Gilardini, L; Guzzaloni, G; Invitti, C; Morabito, F; Viberti, G | 1 |
Dabin, C; del C Gayol, M; Herńandez, GN; Rasia, ML | 1 |
Cupples, LA; D'Agostino, RB; Feng, D; Larson, MG; Levy, D; Lindpaintner, K; O'Donnell, CJ; Tofler, GH; Yang, Q | 1 |
KNOBLOCH, H; SCHULZ, FH | 1 |
ANTONINI, FM; ZILLI, A | 1 |
GAHRTON, G | 1 |
AMRIS, A; AMRIS, CJ | 1 |
SONODA, N | 1 |
HUME, R; MACKAY, N | 1 |
CHEN, JS; HSIEH, WC; HSU, CJ; KUO, TT; LU, WH | 1 |
Hans, M; Juhan-Vague, I | 1 |
Cowan, D; Kaski, JC; Sidhu, JS | 1 |
McIntire, LV; Shiu, YT | 1 |
Cowan, LD; Howard, BV; Lee, ET; Schaefer, CF; Welty, TK; Wild, RA; Yeh, J; Zhang, Y | 1 |
Ariëns, RA; Grant, PJ; Scott, EM | 1 |
Alderman, EL; Howard, BV; Hsia, J; Lindsay, J; Ouyang, P; Silverman, A; Tripputi, M; Van Voorhees, L; Waters, DD | 1 |
Erlinger, TP; Selvin, E | 1 |
Alexy, T; Czopf, J; Demeter, N; Gaal, V; Horvath, B; Juricskay, I; Kesmarky, G; Klabuzai, A; Marton, Z; Szapary, L; Szots, M; Toth, K | 1 |
Bartholovitsch, A; Windberger, U | 1 |
Ariëns, RA; Dunn, EJ | 1 |
Berger, K; John, U; Kentsch, M; Kessler, C; Luedemann, J; Maass, M; Mitusch, R; Rupp, J; Schminke, U; Suter, M; Wood, WG | 1 |
Brown, CA; Carson, AP; Folsom, AR; Rose, KM; Sanford, CP; Stang, PE; Szklo, M | 1 |
Famodu, AA; Umunna, CE; Unuigbe, EI | 1 |
Ganotakis, ES; Kalikaki, A; Kazakou, I; Mikhailidis, DP; Papadakis, JA; Vrentzos, GE | 1 |
Davenport, RJ | 1 |
Elisaf, MS; Goudevenos, J; Mikhailidis, DP; Milionis, HJ; Rizos, E; Seferiadis, K | 1 |
Berthier-Schaad, Y; Coresh, J; Fallin, MD; Fink, NE; Klag, MJ; Liu, Y; Smith, MW; Tracy, RP | 1 |
Brock, DB; Haskell, W; Havlik, RJ; Lakatta, EG; Lohman, K; O'Toole, M; Phillips, CL; Pullen, P; Ribisl, P; Snell, P; Spurgeon, HA; Vaitkevicius, P | 1 |
Aunola, S; Eriksson, JG; Hämäläinen, H; Ilanne-Parikka, P; Keinänen-Kiukaanniemi, S; Lindström, J; Rastas, M; Rönnemaa, T; Tuomilehto, J; Uusitupa, M; Valle, TT; Virtanen, A | 1 |
Einecke, D | 1 |
Reid, HL; Vigilance, JE | 1 |
Carey, HM; Carter, TR; Elliott, MJ; Kull, AD; Morel-Kopp, MC; Philcox, S; Schenck, K; Taylor, BA; Tofler, GH; Ward, C | 1 |
Baumann, PQ; Keating, FK; Schneider, DJ; Sobel, BE; Whitaker, DA | 1 |
Franz, M; Grønbaek, M; Jensen, MK; Koh-Banerjee, P; Rimm, EB; Sampson, L | 1 |
Mertens, I; Van Gaal, LF | 1 |
Chambless, LE; Folsom, AR; Mosley, TH; Ohira, T; Rosamond, WD; Shahar, E | 1 |
Cushman, M; Diez-Roux, AV; Jackson, SA; Ni, H; Ranjit, N; Seeman, T; Shea, S | 1 |
Fuerbringer, R; Gonçalves, LF; Leinig, C; Lindholm, B; Martins, C; Mazza do Nascimento, M; Pecoits-Filho, R; Riella, MC; Stenvinkel, P | 1 |
Berthiaume, Y; Brochiero, E; Chiasson, JL; Coderre, L; Costa, M; Hammana, I; Malet, A; Potvin, S; Rabasa-Lhoret, R | 1 |
Fatourou, EM; Hamilton, G; Mikhailidis, DP; Paraskevas, KI; Seifalian, AM | 1 |
Bokarev, IN; Doronina, AM; Lipinskiĭ, B | 1 |
Amano, M; Fumoto, M; Kondo, H; Kurogochi, M; Nishimura, S; Takimoto, A | 1 |
Crawley, JT; Lane, DA; Lowe, GD; Rumley, A; Woodward, M | 1 |
Chiasson, JL; Cloutier, G; Yu, FT; Zimmer, A | 1 |
Abe, T; Endo, K; Imagawa, U; Obuchi, S | 1 |
Berger, W; Christe, M; Duckert, F; Fritschi, J; Lämmle, B; Marbet, GA; Tran, TH | 1 |
Wardle, EN | 1 |
Daly, JG; Elder, GE; Hadden, DR; Kennedy, AL; Mayne, EE; Montgomery, DA; Weaver, JA | 1 |
Stathakis, NE; Tsianos, EB | 1 |
Burrows, AW | 1 |
Sixma, JJ; Timmermans, AP; van Houwelingen, HC; van Oost, BA; Veldhuyzen, BF | 1 |
Caen, JP; Courillon, A; Galacteros, F; Passa, P; Pintigny, D; Wautier, JL; Wautier, MP | 1 |
Brownlee, M; Cerami, A; Vlassara, H | 1 |
Alfano, G; Candido, A; d'Onofrio, G; Mancini, R; Mango, G; Palla, M; Vallone, R | 1 |
Stuart, J | 1 |
Onwuameze, IC; Reid, HL | 1 |
Bodnar, PN; Donish, RM; Pristupiuk, AM | 1 |
Bodnar, PN; Buglak, NI; Donish, RM; Panasiukova, OR | 1 |
Forman, S; Jones, RL; Jovanovic, L; Peterson, CM | 1 |
Bern, MM; Cassani, MP; Davis, G; Horton, J; Rand, L | 1 |
Adjizian, JC; Droulle, C; Janody, D; Jeunehomme, G; Leutenegger, M; Ostermann, G; Potron, G; Poynard, JP | 1 |
Caen, JP; Galacteros, F; Passa, P; Paton, RC; Pintigny, D; Wautier, JL; Wautier, MP | 1 |
Bodnar, PN | 1 |
Calles-Escandón, J; Córdova-Caballero, MS; Lanzetti-de-Peschard, C; Lozano-Castañeda, O; Padrós-Semorile, MR; Ruiz-Argüelles, GJ | 1 |
Barnes, AJ; Oughton, J | 1 |
Mahfouz, SA; Sharaf, M | 1 |
Blight, L; Calvert, GD; Franklin, J; Gallus, AS; Oliver, J; Wise, P | 1 |
Bron, AJ; Dornan, TL; Mullins, R; Orde-Peckar, C; Poon, PY; Turner, RC | 1 |
Caen, JP; Wautier, JL | 1 |
Sharma, SC | 2 |
Muthukrishnan, V; Singh, M | 1 |
Amado, JA; Mazo, E; Sedano, MC; Vadillo, V; Vidal, JI | 1 |
Coccheri, S; Palareti, G; Poggi, M; Tricarico, MG | 1 |
Abadie, E; Caen, JP; Passa, P; Paton, RC; Pintigny, D; Wautier, JL; Wautier, MP | 1 |
Gaffney, P; Huehns, ER; Joe, F; McVerry, BA; Thorpe, S | 1 |
Alessandri, C; Cordova, C; Musca, A; Salvadori, F; Vezza, E; Violi, F | 1 |
Belch, JJ; Drummond, MM; Forbes, CD; Foulds, WS; Kesson, CM; Lowe, GD; Lowe, JM; MacCuish, AC; Manderson, WG; Reith, S; Wylie, A | 1 |
Arakaki, R; Burchfiel, CM; Chyou, PH; Curb, JD; Rodriguez, BL; Sharp, DS; Yano, K | 1 |
Abruzzese, G; Avellone, G; Bompiani, GD; Cordova, R; De Simone, R; Di Garbo, V; Raneli, G; Rotolo, G | 1 |
Almér, LO; Bergqvist, D; Brunkwall, J; Nilsson, IM | 1 |
Barasch, E; Behar, S; Benderly, M; Caspi, A; Goldbourt, U; Graff, E; Pelled, B; Reicher-Reiss, H; Reisin, L; Roguin, N | 1 |
Binaghi, F; Cannas, F; Caredda, E; Fronteddu, PF; Garau, P; Pitzus, F; Uras, A | 1 |
Carvalho-Sousa, J; Ferrer-Antunes, C; Palmeiro, A | 1 |
Acang, N; Jalil, FD | 1 |
Baker, MR; Bedford, A; Kernohan, E; Knight, T; Lockton, JA; Sahota, P; Smith, Z; Toop, M | 1 |
Lakka, TA; Salonen, JT | 1 |
Robb, DA; Sheikh, MA | 1 |
Lee, AJ; Lowe, GD; Tunstall-Pedoe, H; Woodward, M | 1 |
Ho, CH; Jap, TS; Wang, SP | 1 |
Castiglioni, C; Criqui, M; Longoni, A; Violi, F | 1 |
Cowan, LD; Fabsitz, RR; Howard, BV; Lee, ET; Robbins, DC; Welty, TK; Yeh, JL | 1 |
Kvasnicka, J; Maslowská, H; Perusicová, J; Pochopová, L; Skrha, J | 1 |
Comp, PC; Eichner, JE; McKee, PA; Moore, WE; Qi, H; Reynolds, DW; Schechter, E | 1 |
Burchfiel, CM; Curb, JD; Fujimoto, W; Huang, B; Lu, GY; Rodriguez, BL; Sharp, DS; Yano, K | 1 |
Fabsitz, R; Go, OT; Howard, BV; Knowler, WC; Lee, ET; Robbins, DC; Welty, T; Yeh, J | 1 |
Krolewski, AS; Lipinski, B | 1 |
Carreras, LO; Colorio, CC; Falcón, CR | 1 |
Beacon, H; Beeso, J; Brown, AS; de Belder, A; Edmonds, M; Erusalimsky, JD; Hong, Y; Martin, JF; Sherwood, R | 1 |
Heins, M; Jax, TW; Leschke, M; Pels, K; Reinauer, H; Schoebel, FC; Stein, D; Stiegler, H; Strauer, BE | 1 |
Chan, JC; Chow, CC; Cockram, CS; Ko, GT; Li, JK; So, WY; Tsang, LW; Yeung, VT | 1 |
Carmassi, F; De Negri, F; Morale, M | 1 |
Bach, D; Dieplinger, H; Grabensee, B; Koch, M; Kronenberg, F; Kutkuhn, B; Trenkwalder, E | 1 |
Kessler, C; Mende, S; Rettig, R; Spitzer, C; Stadlmüller, J; Stauske, D; Walther, R | 1 |
Asanuma, H; Funaya, H; Hori, M; Kitakaze, M; Koretsune, Y; Minamino, T; Sato, H | 1 |
Jäger, K; Labs, KH; Marbet, GA; Tsakiris, DA; Tschopl, M | 1 |
Grabensee, B; Koch, M; Kutkuhn, B; Ritz, E | 1 |
Grant, PJ; Ossei-Gerning, N; Wilson, IJ | 1 |
Colman, T; Delgado-Rodriguez, M; Garcia-Fuentes, M; Garcia-Ribes, M; Gonzalez-Lamuño, D; Hernandez-Estefania, R; Pocovi, M; Revuelta, JM | 1 |
Basili, S; Iuliano, L; Longoni, A; Milani, M; Vieri, M; Violi, F | 1 |
Avenirova, EA; Ivanov, SN; Liberman, IS; Vinogradova, TV | 1 |
Cheng, SW; Lau, H; Ting, AC; Wong, J | 1 |
Bourke, C; Hedley, AJ; Janus, ED; Lam, TH; Liu, LJ | 1 |
Carter, AM; Catto, AJ; Grant, PJ | 1 |
Duncan, BB; Heiss, G; Offenbacher, S; Savage, PJ; Schmidt, MI; Wu, KK | 1 |
Binz, JG; Brown, HR; Gaskill, BA; Lancaster, ME; Lenhard, JM; Lightfoot, RM; Paulik, MA; Sundseth, SS; Weiel, JE | 1 |
Aleksic, N; Cooper, LS; Folsom, AR; Nieto, FJ; Rasmussen, ML; Rosamond, WD; Shahar, E; Wu, KK | 1 |
Aleksic, N; Chambless, LE; Folsom, AR; Nieto, FJ; Rasmussen, M; Wu, KK | 1 |
Khodabandehlou, T; Le Dévéhat, C; Vimeux, M | 2 |
Bergqvist, D; Holmberg, A; Sandhagen, B | 1 |
Akbarov, ZS; Rakhimova, GN; Tarakulov, IaKh | 1 |
Lipinska, I; Lipinski, B | 1 |
Choo-Kang, E; Reid, HL; Vigilance, J; Wright-Pascoe, RA | 1 |
Gupta, HL; Jain, A; Narayan, S | 1 |
Cser, A; Horvath, B; Kesmarky, G; Marton, Z; Russai, R; Toth, K; Vekasi, J | 1 |
Böke, E; Erbaş, T; Güvener, M; Güvener, N; Paşaoğlu, I; Tütüncü, NB; Tütüncü, T; Yilmaz, M | 1 |
Bryman, I; Landin-Wilhelmsen, K; Wilhelmsen, L | 1 |
Genovese, S; Parillo, M; Rivellese, AA | 1 |
De Feo, P; Lucidi, P | 1 |
Arber, N; Avitzour, D; Berliner, S; Elishkewich, K; Fusman, R; Izkhacov, E; Rotstein, R; Rubinstein, A; Shapira, I; Zeltser, D | 1 |
Arber, N; Avitzour, D; Berliner, S; Elishkevitz, K; Fusman, R; Koffler, M; Rotstein, R; Shapira, I; Zeltser, D | 1 |
Aso, Y; Fujiwara, Y; Inukai, T; Matsumoto, S; Takemura, Y; Tayama, K | 1 |
Swedenborg, J; Thor, M; Yu, A | 1 |
Almér, LO; Nilsson, IM; Pandolfi, M | 1 |
Alkjaersig, NJ; Etherington, MD; Jamieson, S; Lawford, P; Lincoln, SV; O'Brien, JR | 1 |
Jonsson, A; Wales, JK | 1 |
Bakowski, M; Betteridge, DJ; de Silva, SR; Galton, DJ; Reckless, JP; Taylor, KG | 1 |
Hockaday, TD | 1 |
Stone, MC; Thorp, JM; Wain, JS | 1 |
Gross, W; Zöller, H | 1 |
Boehm, T; deShazo, RD; Evans, R; Levinson, AI; Ward, G | 1 |
Zöller, H | 1 |
Bruwier, M; Daigneux, D; Daubresse, JC; Lefebvre, PJ; Luyckx, A | 1 |
Jones, RL; Peterson, CM | 1 |
Coppolino, E; Cucinotta, D; Di Cesare, E; Quartarone, M; Squadrito, G | 1 |
Bloom, A; Twomey, C | 1 |
Cudworth, AG; De Silva, SR; Patel, H; Shawe, JE | 1 |
Abbate, R; Favilla, S; Gensini, GF; Neri Serneri, GG | 1 |
Chakrabarti, R; Fuller, JH; Jarrett, RJ; Keen, H; Meade, TW; North, WR; Omer, T; Stirling, Y | 1 |
Alberti, KG; Betteridge, DJ; Cudworth, AG; De Silva, SR; Shawe, JE | 1 |
De Hertogh, R; Dormandy, JA; Doumont, J; Gurewich, V; Lambelin, G; Lansen, J; Roncucci, R; Rottiers, R; Souridis, E; Van Stalle, F; Versee, L | 1 |
Brunswick, J; Messer, J | 1 |
Comp, PC; Jacocks, RM; Taylor, FB | 1 |
Agarwal, ML; Bedi, HK; Bedi, T; Bomb, BS; Vyas, BR | 1 |
Barnes, AJ; Dormandy, JA; Hoare, EM | 1 |
Antoniades, HN; Westmoreland, N | 1 |
Ferguson, JC; Mackay, N; Philip, JA; Sumner, DJ | 2 |
Almér, LO; Lilja, B | 1 |
Fischer, T; Heinich, L; Kline, KA; Schmid-Schönbein, H; Volger, E | 1 |
Gallasch, G; Klose, HJ; Schmid-Schönbein, H; Volger, E; von Gosen, J | 1 |
Arkin, CF; Ganda, OP | 1 |
Asai, K; Kitamura, M; Kuzuya, F | 1 |
Gollnick, H; Orfanos, CE; Peter, HH; Weber, S; Zouboulis, CC | 1 |
Jury, DR; Langdon, AG; Robinson, PW | 1 |
Das, AK; Dutta, TK | 1 |
Ardawi, MS; Fatani, HH; Mira, SA; Nasrat, HN | 1 |
Memeh, CU | 1 |
Rosengren, A; Teger-Nilsson, AC; Tsipogianni, A; Wedel, H; Welin, L; Wilhelmsen, L | 1 |
Kanayama, M; Kokubu, M; Makise, J; Saito, E; Suzuki, S; Yamanaka, M | 1 |
Belanger, AJ; D'Agostino, RB; Gagnon, DR; Kannel, WB; Wilson, PW | 1 |
Mechír, J; Mudronová, B; Petrásová, D; Tóthová, E | 1 |
Barradas, MA; Coumar, A; Dandona, P; Ejim, OS; Mikhailidis, DP; Poulter, LW | 1 |
Bellingham, AJ; Flynn, MD; Hammer, MR; John, PN; Leslie, RD | 1 |
Domurat, E; Elias, AN | 1 |
Caen, J; Corvazier, E; Maclouf, J; Pintigny, D; Wautier, JL; Wautier, MP | 1 |
Inokuchi, T; Ishii, M; Isogai, S; Kameyama, M | 1 |
Conoscenti, E; Dolfi, R; Fabbiani, N; Falco, F; Gloria, R; Moronesi, F; Pepe, R; Pisano, L; Stipa, E | 1 |
Bielawiec, M; Borowska, M; Kinalska, I; Kłoczko, J; Wojtukiewicz, M; Zarzycka, B | 1 |
Bock, T; Ladik, T; Landgraf, R; Landgraf-Leurs, MM; Schramm, W; Smolka, B; Spannagl, M | 1 |
Arutiunova, MS; Gogishvili, AV; Kavtaradze, VG; Mamaladze, GT; Takadze, GSh | 1 |
Hamazaki, T; Hasunuma, K; Kobayashi, S; Shishido, H; Yano, S | 1 |
Jones, RL | 1 |
Anderson, J; Farid, NR; Martin, A | 1 |
Larsson, O | 1 |
Farquhar, JW; Isles, TE | 1 |
Banerjee, RN; Bardhan, J; Rao, S | 1 |
Abe, M; Chikatsu, I; Iida, A; Isogai, Y; Mochizuki, K | 1 |
Chmielewski, J | 1 |
Dintenfass, L; Forbes, CD; Milton, GW; Stewart, JH | 1 |
Arkin, C; Smith, SB | 1 |
Banerjee, RN; Kumar, V; Sahni, AL | 1 |
Ishihama, Y; Matsunaga, K; Matsuo, T | 1 |
Matsuda, T | 1 |
Gandolfo, GM | 1 |
Astedt, B; Hedner, U; Svanberg, L | 1 |
Dintenfass, L | 1 |
Chakrabarti, R; Fearnley, GR | 1 |
Baciu, T; Mosora, N; Vincze, J | 1 |
Woolf, N | 1 |
Ivanova, NA | 1 |
Awaji, I; Imamura, H; Ishihama, Y; Matsunaga, K; Matsuo, T | 1 |
Valdorf-Hansen, F | 1 |
Gormsen, J; Laursen, B | 1 |
Grannis, GF | 1 |
Bridges, JM; Mayne, EE; Weaver, JA | 1 |
Ardlie, NG; Rathbone, RL; Schwartz, CJ | 1 |
Tsubone, T | 1 |
Cohen, H; Hart, A; Thorp, JM | 1 |
Foldenauer, A; Suschke, J | 1 |
Barbui, T; Di Luzio, V; Fiaschi, E; Guarnieri, GF; Previato, G; Todesco, S | 1 |
Berchtold, P; Berger, W; Bollinger, A | 1 |
Hajjar, GC; Moser, KM | 1 |
18 review(s) available for fibrinogen and Diabetes Mellitus
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Pathophysiological significance of protein hydrophobic interactions: An emerging hypothesis.
Topics: Animals; Arthritis; Cardiovascular Diseases; Diabetes Mellitus; Fibrin; Fibrinogen; Fibrinolysis; Humans; Hydrophobic and Hydrophilic Interactions; Kidney Diseases; Lung Diseases; Models, Biological; Neoplasms; Nervous System Diseases; Polymerization; Protein Interaction Domains and Motifs; Serum Albumin, Human; Solubility; Thrombosis | 2018 |
Pharmacologic androgen deprivation and cardiovascular disease risk factors: a systematic review.
Topics: Adiposity; Androgen Antagonists; Antineoplastic Agents, Hormonal; Blood Glucose; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus; Dyslipidemias; Fibrinogen; Humans; Hypertension; Insulin Resistance; Male; Prostatic Neoplasms; Risk Factors; Triglycerides | 2015 |
Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk.
Topics: Animals; Cardiovascular Diseases; Diabetes Mellitus; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Thrombosis | 2017 |
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.
Topics: Alcohol Drinking; Biomarkers; Blood Pressure; Body Mass Index; C-Reactive Protein; Cholesterol; Coronary Disease; Databases, Factual; Diabetes Mellitus; Female; Fibrinogen; Humans; Interleukin-6; Leukocyte Count; Lung Diseases; Male; Middle Aged; Motor Activity; Neoplasms; Regression Analysis; Risk Assessment; Risk Factors; Serum Albumin; Sex Factors; Smoking; Stroke; Triglycerides | 2010 |
Fibrinogen and future cardiovascular disease in people with diabetes: aetiological associations and risk prediction using individual participant data from nine community-based prospective cohort studies.
Topics: Adult; Aged; Area Under Curve; Cardiovascular Diseases; Cause of Death; Cohort Studies; Diabetes Complications; Diabetes Mellitus; Female; Fibrinogen; Humans; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; United Kingdom | 2013 |
[From fibrinogen to fibrin and its dissolution].
Topics: Animals; Arteriosclerosis; Carboxypeptidase B2; Cell Movement; Diabetes Mellitus; Disease Models, Animal; Endothelial Cells; Factor XIII; Fibrin; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Insulin Resistance; Metalloproteases; Mice; Mice, Transgenic; Plasminogen Activator Inhibitor 1; Risk Factors; Thrombin; Thrombosis; Wound Healing | 2003 |
In vitro studies of erythrocyte-vascular endothelium interactions.
Topics: Anemia, Sickle Cell; Animals; Cell Adhesion; Diabetes Mellitus; Endothelial Cells; Erythrocytes; Fibrinogen; Fibronectins; Humans; In Vitro Techniques; Malaria, Falciparum; Models, Biological; Rats; Thrombospondins | 2003 |
Genetic and environmental determinants of fibrin structure and function: relevance to clinical disease.
Topics: Afibrinogenemia; Arteriosclerosis; Blood Coagulation; Diabetes Mellitus; Factor XIII; Fibrin; Fibrinogen; Fibrinolysis; Glycosylation; Humans; Hyperhomocysteinemia; Life Style; Lipoproteins; Polymorphism, Genetic; Protein Conformation; RNA Splicing; Structure-Activity Relationship; Thrombosis | 2004 |
Fibrinogen and fibrin clot structure in diabetes.
Topics: Animals; Blood Coagulation; Diabetes Mellitus; Diabetic Angiopathies; Fibrin; Fibrinogen; Humans; Models, Immunological; Signal Transduction | 2004 |
The role of established and emerging risk factors in peripheral vascular graft occlusion.
Topics: C-Reactive Protein; Cholesterol; Coronary Artery Bypass; Diabetes Mellitus; Fibrinogen; Graft Occlusion, Vascular; Homocysteine; Humans; Hypertension; Lipoprotein(a); Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Risk Factors; Smoking; Vascular Surgical Procedures | 2007 |
The acute-phase reaction and haematological stress syndrome in vascular disease.
Topics: Arteriosclerosis; Arthritis, Rheumatoid; Bone Marrow; Diabetes Mellitus; Erythrocyte Deformability; Female; Fibrinogen; Humans; Liver; Male; Neoplasms; Pregnancy; Stress, Physiological; Syndrome; Vascular Diseases | 1984 |
[The endothelium: protective barrier or irritating thorn].
Topics: Anemia, Sickle Cell; Cell Adhesion; Cells, Cultured; Diabetes Mellitus; Endothelium; Erythrocytes; Fibrinogen; Fibronectins; Humans; Leukocytes; Neoplasms; Rheology; Thrombosis | 1982 |
[Role of fibrinogen in arterial vascular pathology].
Topics: Adult; Arteriosclerosis; Blood Viscosity; Cardiovascular Diseases; Clinical Trials as Topic; Cohort Studies; Diabetes Mellitus; Female; Fibrinogen; Humans; Male; Middle Aged; Obesity; Platelet Aggregation; Prospective Studies; Risk Factors; Sex Factors; Smoking; Thrombosis | 1997 |
Fibrin(ogen) and diabetes mellitus: don't forget fibrinolysis.
Topics: Arteriosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Angiopathies; Fibrin; Fibrinogen; Fibrinolysis; Humans; Plasminogen Activator Inhibitor 1; Risk Factors | 1997 |
Liver protein synthesis in physiology and in disease states.
Topics: Albumins; Altitude; Diabetes Mellitus; Diet; Exercise; Fibrinogen; Growth Hormone; Humans; Kidney Diseases; Kinetics; Liver; Protein Biosynthesis; Smoking | 2002 |
[Coagulation and fibrinolytic system in the vascular risks diabetes mellitus and hyperlipoproteinemia (author's transl)].
Topics: Adult; Aged; Antithrombins; Blood Coagulation; Cholesterol; Diabetes Mellitus; Diabetic Angiopathies; Female; Fibrinogen; Fibrinolysis; Humans; Hyperlipidemias; Male; Middle Aged; Platelet Aggregation; Risk; Thrombocytopenia; Triglycerides | 1978 |
[Role of blood clotting and fibrinolytic disorders in diabetics in the development of pathological changes in blood vessels].
Topics: Blood Coagulation Disorders; Blood Platelet Disorders; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Factor VIII; Fibrinogen; Fibrinolysis; Humans; Insulin; Platelet Adhesiveness; Trypsin Inhibitors | 1973 |
19 trial(s) available for fibrinogen and Diabetes Mellitus
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Non-traditional biomarkers and incident diabetes in the Diabetes Prevention Program: comparative effects of lifestyle and metformin interventions.
Topics: Adiponectin; Biomarkers; Chemokine CCL2; Diabetes Mellitus; E-Selectin; Fibrinogen; Hypoglycemic Agents; Intercellular Adhesion Molecule-1; Interleukin-6; Leptin; Life Style; Metformin; Tissue Plasminogen Activator | 2019 |
Improved sleep quality in older adults with insomnia reduces biomarkers of disease risk: pilot results from a randomized controlled comparative efficacy trial.
Topics: Aged; Allostasis; Biomarkers; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cognitive Behavioral Therapy; Diabetes Mellitus; Female; Fibrinogen; Glycated Hemoglobin; Humans; Insulin; Male; Middle Aged; Patient Education as Topic; Pilot Projects; Sleep Initiation and Maintenance Disorders; Tai Ji; Treatment Outcome; Triglycerides | 2015 |
Evaluation of risk markers fluctuation during an initial therapy with rosiglitazon in patients suffering from metabolic syndrome.
Topics: Biomarkers; C-Reactive Protein; Diabetes Mellitus; Dose-Response Relationship, Drug; Female; Fibrinogen; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Longitudinal Studies; Male; Metabolic Syndrome; Risk Factors; Rosiglitazone; Thiazolidinediones; Treatment Outcome; Uric Acid | 2009 |
The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients.
Topics: Aged; Anti-Inflammatory Agents; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Diabetes Mellitus; Endothelium, Vascular; Female; Fibrinogen; Humans; Insulin Resistance; Male; Middle Aged; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazolidinediones; Transcription Factors; Vasodilator Agents | 2003 |
Postmenopausal hormone therapy is associated with atherosclerosis progression in women with abnormal glucose tolerance.
Topics: Adult; Aged; Blood Glucose; C-Reactive Protein; Canada; Comorbidity; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus; Disease Progression; Drug Combinations; Estrogens, Conjugated (USP); Female; Fibrinogen; Follow-Up Studies; Glucose Intolerance; Hormone Replacement Therapy; Humans; Hysterectomy; Inflammation; Insulin; Insulin Resistance; Lipoproteins, HDL; Medroxyprogesterone Acetate; Middle Aged; Obesity; Postmenopause; Prospective Studies; Single-Blind Method; Triglycerides; United States | 2004 |
Walking may be related to less vascular stiffness in the Activity Counseling Trial (ACT).
Topics: Adult; Aged; Blood Flow Velocity; Cholesterol, HDL; Cholesterol, LDL; Compliance; Diabetes Mellitus; Diastole; Female; Fibrinogen; Health Promotion; Humans; Male; Middle Aged; Models, Theoretical; Motor Activity; Oxygen Consumption; Patient Education as Topic; Physical Fitness; Surveys and Questionnaires; Systole; United States; Vascular Resistance; Walking | 2005 |
Improved fibrinolysis by an intensive lifestyle intervention in subjects with impaired glucose tolerance. The Finnish Diabetes Prevention Study.
Topics: Adult; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet; Exercise; Female; Fibrinogen; Fibrinolysis; Finland; Follow-Up Studies; Glucose Intolerance; Humans; Life Style; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Weight Loss | 2005 |
The effects of clofibrate on plasma glucose, lipoproteins, fibrinogen, and other biochemical and haematological variables in patients with mature onset diabetes mellitus.
Topics: Aged; Blood Glucose; Blood Viscosity; Cholesterol; Clinical Trials as Topic; Clofibrate; Diabetes Mellitus; Double-Blind Method; Fatty Acids, Nonesterified; Female; Fibrinogen; Humans; Lipoproteins; Male; Middle Aged; Triglycerides | 1980 |
Blood viscosity, glycaemic control and retinopathy in insulin-dependent diabetes.
Topics: Adult; Blood Glucose; Blood Viscosity; Cross-Sectional Studies; Diabetes Mellitus; Diabetic Retinopathy; Fibrinogen; Glycated Hemoglobin; Humans; Insulin; Male; Middle Aged | 1982 |
Plasma fibrinogen levels and their correlates in 6457 coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study.
Topics: Age Factors; Aged; Bezafibrate; Body Mass Index; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Diabetes Complications; Diabetes Mellitus; Female; Fibrinogen; Humans; Hypertension; Israel; Male; Middle Aged; Motor Activity; Multivariate Analysis; Myocardial Infarction; Risk Factors; Sex Factors; Smoking; Triglycerides | 1995 |
Relation between risk factors and cardiovascular complications in patients with peripheral vascular disease. Results from the A.D.E.P. study.
Topics: Adult; Aged; Cardiovascular Diseases; Cerebrovascular Disorders; Comorbidity; Diabetes Mellitus; Disease Susceptibility; Female; Fibrinogen; Follow-Up Studies; Humans; Hypertension; Incidence; Italy; Leukocyte Count; Logistic Models; Male; Middle Aged; Odds Ratio; Peripheral Vascular Diseases; Phthalic Acids; Platelet Aggregation Inhibitors; Prospective Studies; Receptors, Thromboxane; Risk Factors; Smoking; Vascular Surgical Procedures | 1996 |
Determinants of fibrinogen in an Italian population suffering from claudication. Lower fibrinogen in the south compared to middle and north of Italy. The ADEP Group.
Topics: Diabetes Mellitus; Double-Blind Method; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Intermittent Claudication; Italy; Phthalic Acids; Platelet Aggregation Inhibitors; Risk Factors; Smoking; Vascular Surgical Procedures | 1998 |
Cardiac malformations and hypertension, but not metabolic risk factors, are common in Turner syndrome.
Topics: Adult; Blood Pressure; Body Weight; Cardiovascular Diseases; Chromosomes; Diabetes Mellitus; Female; Fibrinogen; Gonadal Steroid Hormones; Heart Defects, Congenital; Humans; Hypertension; Karyotyping; Life Style; Lipids; Male; Middle Aged; Risk Factors; Turner Syndrome | 2001 |
Clofibrate and diabetes control in patients treated with oral hypoglycaemic agents.
Topics: Blood Glucose; Clinical Trials as Topic; Clofibrate; Diabetes Mellitus; Female; Fibrinogen; Glycosuria; Humans; Hypoglycemic Agents; Lipids; Male; Middle Aged; Placebos | 1979 |
Clofibrate in insulin-dependent diabetes.
Topics: Adolescent; Adult; Aged; Blood Glucose; Clofibrate; Diabetes Mellitus; Evaluation Studies as Topic; Female; Fibrinogen; Humans; Lipoproteins; Male; Middle Aged | 1979 |
Metformin and clofibrate in maturity onset diabetes mellitus: advantages of combined treatment.
Topics: Alanine; Blood Glucose; Cholesterol; Circadian Rhythm; Clofibrate; Diabetes Mellitus; Drug Synergism; Fibrinogen; Glycerol; Humans; Hydroxybutyrates; Lactates; Lipoproteins; Metformin; Triglycerides | 1979 |
Effects of long-term treatment with suloctidil on blood viscosity, erythrocyte deformability and total fibrinogen plasma levels in diabetic patients.
Topics: Adult; Aged; Blood Viscosity; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Erythrocytes; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Propanolamines; Suloctidil; Time Factors | 1979 |
The use of sulodexide in the treatment of peripheral vasculopathy accompanying metabolic diseases. Controlled study in hyperlipidemic and diabetic subjects.
Topics: Adult; Aged; Antithrombin III; Cholesterol, HDL; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Female; Fibrinogen; Glycosaminoglycans; Humans; Hyperlipidemias; Male; Middle Aged; Triglycerides; Vascular Diseases | 1986 |
238 other study(ies) available for fibrinogen and Diabetes Mellitus
Article | Year |
---|---|
Inflammatory Markers and Mortality in Diabetic Versus Idiopathic Gastroparesis.
Topics: Biomarkers; C-Reactive Protein; Diabetes Mellitus; Factor VIII; Fibrinogen; Gastroparesis; Humans; Inflammation; Retrospective Studies; Thrombophilia | 2022 |
Penehyclidine hydrochloride suppresses inflammation response and reduces podocyte injury in diabetic nephropathy by targeting fibrinogen-like protein 2.
Topics: Animals; Caspase 1; Diabetes Mellitus; Diabetic Nephropathies; Female; Fibrinogen; Humans; Inflammation; Male; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Podocytes; Quinuclidines; Rats; Toll-Like Receptor 4 | 2022 |
Procoagulant and anticoagulant plasma indicators in diabetic dogs showing increased antithrombin III levels in canine diabetes mellitus.
Topics: Animals; Anticoagulants; Antithrombin III; Diabetes Mellitus; Dog Diseases; Dogs; Fibrinogen; Hemostasis | 2022 |
High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohort.
Topics: Albumins; Cohort Studies; Coronary Artery Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Inflammation; Male; Percutaneous Coronary Intervention; Risk Factors; Stroke; Time Factors; Treatment Outcome | 2022 |
Risk Factors for Dupuytren's Contracture: A Case-Control Study.
Topics: Case-Control Studies; Chlorides; Cystatin C; Diabetes Mellitus; Dupuytren Contracture; Fibrinogen; Humans; Male; Retrospective Studies; Risk Factors; ROC Curve | 2022 |
The Association of Inflammatory Factors With Peripheral Neuropathy: The Study of Women's Health Across the Nation.
Topics: Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus; Female; Fibrinogen; Humans; Inflammation; Metabolic Syndrome; Middle Aged; Obesity; Peripheral Nervous System Diseases; Risk Factors; Women's Health | 2023 |
Etiological analysis of patients with sudden sensorineural hearing loss: a prospective case-control study.
Topics: Case-Control Studies; Diabetes Mellitus; Fibrinogen; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; Hypertension; Prognosis | 2023 |
Preclinical animal study of electrospun poly (l-lactide-co-caprolactone) and formulated porcine fibrinogen for full-thickness diabetic wound regeneration.
Topics: Animals; Diabetes Mellitus; Fibrinogen; Polyesters; Rats; Swine; Tissue Engineering; Tissue Scaffolds | 2023 |
Establishment of a potent weighted risk model for determining the progression of diabetic kidney disease.
Topics: Cross-Sectional Studies; Diabetes Mellitus; Diabetic Nephropathies; Fibrinogen; Glycated Hemoglobin; Humans; Uric Acid | 2023 |
Prevalence of obesity and obesity-associated muscle wasting in patients on peritoneal dialysis.
Topics: Adult; Aged; Biomarkers; Body Composition; C-Reactive Protein; Cross-Sectional Studies; Diabetes Mellitus; Female; Fibrinogen; Humans; Inflammation Mediators; Italy; Kidney Failure, Chronic; Male; Middle Aged; Obesity; Peritoneal Dialysis; Prevalence; Risk Assessment; Risk Factors; Sarcopenia | 2019 |
New Insights into the Association between Fibrinogen and Coronary Atherosclerotic Plaque Vulnerability: An Intravascular Optical Coherence Tomography Study.
Topics: Acute Coronary Syndrome; Adult; Aged; Biomarkers; Body Mass Index; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Diabetes Mellitus; Female; Fibrinogen; Humans; Male; Middle Aged; Plaque, Atherosclerotic; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Rupture, Spontaneous; Tomography, Optical Coherence | 2019 |
Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19.
Topics: Adult; Aged; Area Under Curve; Betacoronavirus; Biomarkers; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Diabetes Complications; Diabetes Mellitus; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Interleukin-6; Male; Middle Aged; Pandemics; Pneumonia, Viral; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; SARS-CoV-2; Sensitivity and Specificity; Severity of Illness Index; Thrombin Time | 2020 |
Fibrinogen is associated with glucose metabolism and cardiovascular outcomes in patients with coronary artery disease.
Topics: Aged; Biomarkers; Blood Glucose; Coronary Artery Disease; Diabetes Mellitus; Disease Progression; Fasting; Female; Fibrinogen; Glycated Hemoglobin; Humans; Male; Middle Aged; Myocardial Revascularization; Prediabetic State; Progression-Free Survival; Risk Assessment; Risk Factors; Time Factors; Up-Regulation | 2020 |
Factor VIII and Functional Protein C Activity in Critically Ill Patients With Coronavirus Disease 2019: A Case Series.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Antithrombins; Betacoronavirus; C-Reactive Protein; Comorbidity; Coronavirus Infections; COVID-19; Critical Illness; Diabetes Mellitus; Dyslipidemias; Extracorporeal Membrane Oxygenation; Factor VIII; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hypertension; International Normalized Ratio; Male; Middle Aged; Obesity; Pandemics; Partial Thromboplastin Time; Pneumonia, Viral; Protein C; Prothrombin Time; Renal Dialysis; Renal Insufficiency, Chronic; Respiration, Artificial; Respiratory Distress Syndrome; SARS-CoV-2; Thrombophilia | 2020 |
Cardiorespiratory Fitness Predicted by Fibrinogen and Leptin Concentrations in Children with Obesity and Risk for Diabetes: A Cross-Sectional Study and a ROC Curve Analysis.
Topics: Adiponectin; Adolescent; Blood Glucose; Cardiorespiratory Fitness; Case-Control Studies; Child; Cross-Sectional Studies; Diabetes Mellitus; Exercise Test; Female; Fibrinogen; Humans; Insulin; Leptin; Male; Obesity; Oxygen Consumption; Risk Factors; ROC Curve | 2021 |
Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study.
Topics: Aged; Biomarkers; Blood Glucose; Cause of Death; Coronary Artery Disease; Diabetes Mellitus; Female; Fibrinogen; Glycated Hemoglobin; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Prediabetic State; Prospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2021 |
Thrombogenicity markers for early diagnosis and prognosis in COVID-19: a change from the current paradigm?
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Black or African American; Cardiovascular Diseases; Comorbidity; COVID-19; COVID-19 Testing; Diabetes Mellitus; Early Diagnosis; Female; Fibrin; Fibrin Clot Lysis Time; Fibrinogen; Hospitalization; Humans; Hyperlipidemias; L-Lactate Dehydrogenase; Male; Middle Aged; Obesity; Organ Dysfunction Scores; Prognosis; Prospective Studies; SARS-CoV-2; Thrombelastography; Thrombophilia; Treatment Outcome; White People | 2021 |
Association of fibrinogen level with early neurological deterioration among acute ischemic stroke patients with diabetes.
Topics: Aged; Brain Ischemia; Cohort Studies; Diabetes Mellitus; Female; Fibrinogen; Humans; Male; Middle Aged; Odds Ratio; Retrospective Studies; Risk Factors; Stroke | 2017 |
Air pollution and diabetes-related biomarkers in non-diabetic adults: A pathway to impaired glucose metabolism?
Topics: Adiponectin; Aged; Air Pollution; Biomarkers; C-Reactive Protein; Cohort Studies; Diabetes Mellitus; Environmental Exposure; Female; Fibrinogen; Germany; Glucose; Humans; Male; Middle Aged; Prospective Studies | 2019 |
Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study.
Topics: Acute Coronary Syndrome; Aged; Biomarkers; Blood Glucose; China; Diabetes Mellitus; Female; Fibrinogen; Glycated Hemoglobin; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Prospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2019 |
Glucose metabolism affects coagulation factors: The NEO study.
Topics: Aged; Biomarkers; Blood Coagulation; Blood Coagulation Factors; Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus; Factor IX; Factor VIII; Factor XI; Fasting; Female; Fibrinogen; Glucose Intolerance; Glycated Hemoglobin; Humans; Male; Middle Aged; Netherlands; Postprandial Period; Prospective Studies | 2019 |
Factors related to the initial stroke severity of posterior circulation ischemic stroke.
Topics: Aged; Blood Glucose; Blood Sedimentation; Brain Damage, Chronic; C-Reactive Protein; Cerebral Angiography; Cerebrovascular Circulation; Comorbidity; Diabetes Mellitus; Diffusion Magnetic Resonance Imaging; Disease Progression; Female; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Infarction, Posterior Cerebral Artery; Intracranial Embolism; Ischemic Attack, Transient; Leukocyte Count; Male; Middle Aged; Registries; Republic of Korea; Risk; Risk Factors; Severity of Illness Index; Smoking; Symptom Assessment; Treatment Outcome | 2013 |
Number of teeth, C-reactive protein, fibrinogen and cardiovascular mortality: a 15-year follow-up study in a Finnish cohort.
Topics: Age Factors; Aged; Body Mass Index; C-Reactive Protein; Case-Control Studies; Cohort Studies; Coronary Artery Disease; Dental Calculus; Dental Caries; Dentition; Diabetes Mellitus; Female; Fibrinogen; Finland; Follow-Up Studies; Humans; Hypertension; Lipoproteins; Longitudinal Studies; Male; Middle Aged; Mouth, Edentulous; Periapical Diseases; Pericoronitis; Periodontal Diseases; Prospective Studies; Smoking | 2014 |
High plasma estradiol interacts with diabetes on risk of dementia in older postmenopausal women.
Topics: Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Case-Control Studies; Cohort Studies; Dementia; Diabetes Mellitus; Estradiol; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; France; Humans; Inflammation; Multivariate Analysis; Postmenopause; Proportional Hazards Models; Risk; Risk Factors; Testosterone; Thrombin; Thrombophilia | 2014 |
The roles of a novel anti-inflammatory factor, milk fat globule-epidermal growth factor 8, in patients with coronary atherosclerotic heart disease.
Topics: Angina Pectoris; Angina, Unstable; Antigens, Surface; C-Reactive Protein; China; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus; Female; Fibrinogen; Humans; Male; Middle Aged; Milk Proteins; Myocardial Infarction; Risk Factors; Severity of Illness Index; Sex Factors; Smoking; Triglycerides | 2014 |
Peripheral arterial disease, gender, and depression in the Heart and Soul Study.
Topics: Aged; Biomarkers; Chi-Square Distribution; Comorbidity; Depression; Diabetes Mellitus; Female; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Peripheral Arterial Disease; Prevalence; Prospective Studies; Risk Factors; Sex Factors; Smoking; Time Factors | 2014 |
Atherosclerosis, some serum inflammatory markers in psoriasis.
Topics: Adipokines; Adolescent; Adult; Aged; Aorta; Atherosclerosis; Biomarkers; Blood Cell Count; C-Reactive Protein; Carotid Intima-Media Thickness; Case-Control Studies; Chitinase-3-Like Protein 1; Comorbidity; Complement C3; Complement C4; Diabetes Mellitus; Dyslipidemias; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hypertension; Inflammation; Lectins; Male; Middle Aged; Psoriasis; Smoking; Vascular Resistance; Young Adult | 2014 |
Control of diabetes and fibrinogen levels as well as improvement in health care might delay low cognitive performance in societies aging progressively.
Topics: Adult; Aged; Aging; Brazil; Cognition Disorders; Cross-Sectional Studies; Diabetes Mellitus; Female; Fibrinogen; Humans; Male; Middle Aged; Prevalence; Socioeconomic Factors | 2015 |
Impact of diabetes on fibrinogen levels and its relationship with platelet reactivity and coronary artery disease: A single-centre study.
Topics: Aged; Aged, 80 and over; Blood Glucose; Blood Platelets; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus; Diabetic Angiopathies; Female; Fibrinogen; Humans; Male; Middle Aged; Platelet Aggregation; Prevalence | 2015 |
Comparison of risk factors for cardiovascular disease in hemodialysis and peritoneal dialysis patients.
Topics: Adult; Atherosclerosis; Blood Glucose; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus; Female; Fibrinogen; Homocysteine; Humans; Inflammation; Male; Metabolic Syndrome; Middle Aged; Peritoneal Dialysis; Renal Dialysis; Risk Factors; Triglycerides | 2015 |
Identification of ageing-associated naturally occurring peptides in human urine.
Topics: Adult; Aged; Aged, 80 and over; Aging; Cardiovascular Diseases; Collagen; Diabetes Mellitus; Female; Fibrinogen; Humans; Kidney Diseases; Male; Middle Aged; Peptides; Proteome; Uromodulin; Young Adult | 2015 |
Glucose intolerance in cystic fibrosis as a determinant of pulmonary function and clinical status.
Topics: Adiponectin; Adolescent; Adult; Albumins; Blood Glucose; Body Mass Index; Cystic Fibrosis; Diabetes Mellitus; Female; Fibrinogen; Glucose Intolerance; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Insulin-Secreting Cells; Lipids; Male; Respiratory Function Tests; Young Adult | 2015 |
Proteomic Analysis of Plasma in Adult Active Pulmonary Tuberculosis Patients with Diabetes Mellitus.
Topics: Adolescent; Adult; Aged; alpha 1-Antitrypsin; Apolipoprotein A-I; Case-Control Studies; CD5 Antigens; Clusterin; Diabetes Complications; Diabetes Mellitus; Electrophoresis, Gel, Two-Dimensional; Female; Fibrinogen; Haptoglobins; Humans; Male; Mass Spectrometry; Middle Aged; Mycobacterium tuberculosis; Peptides; Proteomics; Tuberculosis, Pulmonary; Vitamin D-Binding Protein; Young Adult | 2015 |
Micro-RNA-126 Reduces the Blood Thrombogenicity in Diabetes Mellitus via Targeting of Tissue Factor.
Topics: 3' Untranslated Regions; Aged; Binding Sites; Cell Line; Diabetes Mellitus; Endothelial Cells; Female; Fibrinogen; Gene Expression Regulation; Genes, Reporter; Hemostasis; Humans; Hypoglycemic Agents; Male; MicroRNAs; Middle Aged; Monocytes; RNA Interference; Thromboplastin; Thrombosis; Time Factors; Transfection; Vascular Cell Adhesion Molecule-1 | 2016 |
The association of uric acid with leukoaraiosis.
Topics: Aged; Aged, 80 and over; Alcohol Drinking; Asian People; Cognitive Dysfunction; Cross-Sectional Studies; Diabetes Mellitus; Dizziness; Dyslipidemias; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Headache; Homocysteine; Humans; Hypertension; Hyperuricemia; Leukoaraiosis; Male; Middle Aged; Multivariate Analysis; Risk Factors; Smoking; Uric Acid | 2017 |
On societal and hemostatic changes.
Topics: Biomedical Research; Diabetes Mellitus; Factor XIII; Fibrinogen; Genetic Variation; Hemostasis; Humans; Politics; Thrombosis | 2016 |
What makes platelets angry: diabetes, fibrinogen, obesity, and impaired response to antiplatelet therapy?
Topics: Diabetes Mellitus; Fibrinogen; Humans; Obesity; Platelet Aggregation; Platelet Aggregation Inhibitors | 2008 |
Plasma fibrinogen level may predict critical coronary artery stenosis in young adults with myocardial infarction.
Topics: Adult; Antithrombin III; Biomarkers; Coronary Angiography; Coronary Stenosis; Diabetes Mellitus; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Male; Myocardial Infarction; Predictive Value of Tests; Protein C; Protein S; Risk Factors; Smoking | 2009 |
Enhanced post-clopidogrel platelet reactivity in diabetic patients is independently related to plasma fibrinogen level but not to glycemic control.
Topics: Blood Glucose; Clopidogrel; Diabetes Mellitus; Fibrinogen; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticlopidine | 2009 |
Association of optimism and pessimism with inflammation and hemostasis in the Multi-Ethnic Study of Atherosclerosis (MESA).
Topics: Adaptation, Psychological; Adult; Aged; Aged, 80 and over; Atherosclerosis; Attitude to Health; Biomarkers; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Mellitus; Ethnicity; Female; Fibrinogen; Health Behavior; Hemostasis; Humans; Hypertension; Inflammation; Interleukin-6; Male; Middle Aged; Personality; Risk Factors | 2010 |
Study of fibrinogen in patients with diabetes mellitus.
Topics: Case-Control Studies; Coronary Artery Disease; Cross-Sectional Studies; Diabetes Mellitus; Female; Fibrinogen; Humans; Male; Middle Aged | 2010 |
Magnesium intake in relation to systemic inflammation, insulin resistance, and the incidence of diabetes.
Topics: Adult; C-Reactive Protein; Diabetes Mellitus; Female; Fibrinogen; Humans; Inflammation; Insulin Resistance; Interleukin-6; Magnesium; Male; Young Adult | 2010 |
Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes.
Topics: Aged; Aged, 80 and over; Alcohol Drinking; Body Mass Index; Cholesterol; Cholesterol, HDL; Diabetes Mellitus; Diet; Dietary Carbohydrates; Fatty Acids, Monounsaturated; Female; Fibrinogen; Humans; Insulin Resistance; Life Style; Lipids; Male; Proportional Hazards Models; Prospective Studies; Risk Factors; Sex Factors; Triglycerides | 2010 |
Coagulation factor VIII activity in diabetic patients.
Topics: Blood Glucose; Diabetes Complications; Diabetes Mellitus; Factor VIII; Fibrinogen; Humans; Risk Factors; Thrombosis | 2011 |
Diabetes mellitus is associated with shortened activated partial thromboplastin time and increased fibrinogen values.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Diabetes Mellitus; Female; Fibrinogen; Glycated Hemoglobin; Hemostasis; Humans; Male; Middle Aged; Partial Thromboplastin Time | 2011 |
Antithrombin III associated with fibrinogen predicts the risk of cerebral ischemic stroke.
Topics: Adult; Aged; Antithrombin III; Biomarkers; Brain Ischemia; C-Reactive Protein; Costs and Cost Analysis; Diabetes Mellitus; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Humans; Hyperlipidemias; Male; Middle Aged; Predictive Value of Tests; Risk Factors; Stroke; Thrombin; Tissue Plasminogen Activator | 2011 |
The association between leptin and insulin levels in adults with cystic fibrosis.
Topics: Adult; Area Under Curve; Blood Glucose; Body Mass Index; Canada; Cohort Studies; Cystic Fibrosis; Diabetes Mellitus; Fasting; Female; Fibrinogen; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Leptin; Male; Prospective Studies | 2012 |
Markers of inflammation, metabolic risk factors, and incident heart failure in American Indians: the Strong Heart Study.
Topics: Aged; Biomarkers; C-Reactive Protein; Diabetes Mellitus; Female; Fibrinogen; Health Surveys; Heart Failure; Humans; Indians, North American; Inflammation; Male; Metabolic Syndrome; Middle Aged; Obesity; Prevalence; Proportional Hazards Models; Risk Factors; United States | 2012 |
Novel pathway of iron‑induced blood coagulation: implications for diabetes mellitus and its complications.
Topics: Blood Coagulation; Diabetes Complications; Diabetes Mellitus; Fibrin; Fibrinogen; Humans; Iron; Iron Overload | 2012 |
Hyperfibrinogenemia in patients of diabetes mellitus in relation to glycemic control and urinary albumin excretion rate.
Topics: Albuminuria; Blood Coagulation; Blood Glucose; Diabetes Mellitus; Fibrinogen; Humans | 2002 |
Hormone replacement therapy and its relationship to lipid and glucose metabolism in diabetic and nondiabetic postmenopausal women: results from the Third National Health and Nutrition Examination Survey (NHANES III).
Topics: Adult; Aged; Blood Glucose; Cholesterol; Diabetes Mellitus; Estrogen Replacement Therapy; Female; Fibrinogen; Glucose Tolerance Test; Health Surveys; Human Growth Hormone; Humans; Hyperlipidemias; Insulin; Lipids; Lipoproteins; Postmenopause | 2002 |
Prevalence and concomitants of glucose intolerance in European obese children and adolescents.
Topics: Adolescent; Birth Weight; Blood Glucose; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Child; Cohort Studies; Diabetes Mellitus; Female; Fibrinogen; Glucose Intolerance; Humans; Insulin Resistance; Italy; Lipids; Male; Obesity; Prevalence; Puberty; Risk Factors; Uric Acid | 2003 |
Haemorheological variables in a rat model of hypertriglyceridaemic obesity and diabetes.
Topics: Animals; Blood Glucose; Blood Viscosity; Body Weight; Cholesterol; Diabetes Mellitus; Disease Models, Animal; Erythrocyte Deformability; Fibrinogen; Glucose Tolerance Test; Hematocrit; Hemoglobins; Male; Obesity; Rats; Rats, Inbred Strains; Rheology; Statistics, Nonparametric; Triglycerides | 2002 |
A genome-wide search for genes affecting circulating fibrinogen levels in the Framingham Heart Study.
Topics: Adult; Arteriosclerosis; Chromosomes, Human, Pair 10; Chromosomes, Human, Pair 2; Chromosomes, Human, Pair 7; Cohort Studies; Coronary Disease; Diabetes Mellitus; Family Health; Female; Fibrinogen; Genetic Predisposition to Disease; Genome, Human; Genotype; Humans; Hypertension; Lod Score; Male; Middle Aged; Obesity; Polymorphism, Restriction Fragment Length; Risk Factors | 2003 |
[Fibrinogen in diabetes mellitus].
Topics: Coagulants; Diabetes Mellitus; Fibrinogen; Hemostatics; Humans | 1955 |
[Plasmatic fibrinogen in the vascular complications of diabetes].
Topics: Blood Vessels; Coagulants; Diabetes Complications; Diabetes Mellitus; Fibrinogen; Hemostatics; Humans | 1959 |
MICROSPECTROPHOTOMETRIC QUANTITATION OF THE PERIODIC ACID-SCHIFF (PAS) REACTION IN HUMAN NEUTROPHIL LEUKOCYTES BASED ON A MODEL SYSTEM OF GLYCOGEN MICRODROPLETS.
Topics: Absorption; Acidosis; Amylases; Biomedical Research; Blood Glucose; Coloring Agents; Diabetes Mellitus; Fibrinogen; Glycogen; Glycosuria; Heparin; Histocytochemistry; Humans; Insulin; Leukocytes; Neutrophils; Periodic Acid; Pharmacology; Research; Spectrophotometry; Staining and Labeling; Sulfuric Acids | 1964 |
TURNOVER AND DISTRIBUTION OF 131-IODINE-LABELLED HUMAN FIBRINOGEN.
Topics: Arteriosclerosis; Blood Coagulation Tests; Coronary Disease; Diabetes Mellitus; Fibrinogen; Geriatrics; Humans; Intervertebral Disc Displacement; Iodine; Iodine Isotopes; Liver Cirrhosis; Lung Neoplasms; Metabolism; Radiometry; Thrombophlebitis; Thrombosis | 1964 |
[STUDIES ON THE THROMBIN TEST IN LIVER AND BILIARY TRACT DISEASES].
Topics: Biliary Tract Diseases; Blood Coagulation Disorders; Blood Coagulation Tests; Diabetes Mellitus; Fibrinogen; Humans; Liver Diseases; Nephritis; Prothrombin Time; Thrombin | 1964 |
FIBRINOLYTIC ACTIVITY IN DIABETES MELLITUS.
Topics: Cholesterol; Coronary Disease; Diabetes Mellitus; Diabetic Angiopathies; Fibrinogen; Fibrinolysis; Humans; Thrombolytic Therapy | 1964 |
PLASMA FIBRINOGEN ON PATIENTS OF CEREBROVASCULAR DISEASE.
Topics: Blood Chemical Analysis; Cerebral Hemorrhage; Cerebrovascular Disorders; Diabetes Mellitus; Fibrinogen; Humans; Hypertension; Intracranial Embolism; Intracranial Embolism and Thrombosis | 1964 |
Associations of postmenopausal hormone therapy with markers of hemostasis and inflammation and lipid profiles in diabetic and nondiabetic american Indian women: the strong heart study.
Topics: Aged; Analysis of Variance; Biomarkers; Blood Glucose; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Diabetes Mellitus; Estrogen Replacement Therapy; Female; Fibrinogen; Homeostasis; Humans; Indians, North American; Lipids; Lipoproteins; Middle Aged; Plasminogen Activator Inhibitor 1; Postmenopause; Risk Factors; Triglycerides; United States | 2004 |
Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Pressure Determination; Brachial Artery; C-Reactive Protein; Comorbidity; Cross-Sectional Studies; Diabetes Mellitus; Female; Fibrinogen; Glomerular Filtration Rate; Health Surveys; Humans; Hypercholesterolemia; Hypertension; Kidney Diseases; Male; Middle Aged; Peripheral Vascular Diseases; Prevalence; Racial Groups; Risk Factors; Smoking; Tibial Arteries; United States | 2004 |
Hemorheological disturbances in patients with chronic cerebrovascular diseases.
Topics: Adult; Alcohol Drinking; Blood Viscosity; Brain Ischemia; Cerebrovascular Circulation; Cerebrovascular Disorders; Chronic Disease; Diabetes Mellitus; Erythrocyte Aggregation; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Hyperlipidemias; Hypertension; Ischemic Attack, Transient; Male; Middle Aged; Myocardial Ischemia; Reference Values; Risk Factors; Smoking | 2004 |
Hemorheology in spontaneous animal endocrinopathies.
Topics: Animals; Blood Viscosity; Cholesterol; Cushing Syndrome; Diabetes Mellitus; Dogs; Endocrine System Diseases; Erythrocyte Aggregation; Fibrinogen; Hemorheology; Triglycerides | 2004 |
Asymptomatic carotid atherosclerosis is associated with circulating chlamydia pneumoniae DNA in younger normotensive subjects in a general population survey.
Topics: Adult; Aged; Aged, 80 and over; Bacteremia; C-Reactive Protein; Carotid Artery Diseases; Carotid Artery, Common; Chlamydophila Infections; Chlamydophila pneumoniae; Comorbidity; Cross-Sectional Studies; Diabetes Mellitus; DNA, Bacterial; Female; Ferritins; Fibrinogen; Germany; Humans; Hypercholesterolemia; Hypertension; Inflammation; Male; Middle Aged; Polymerase Chain Reaction; Risk Factors; Tunica Intima; Tunica Media; Ultrasonography | 2005 |
Migraine and other headaches: associations with Rose angina and coronary heart disease.
Topics: Adult; Aged; Arteriosclerosis; Black or African American; Chest Pain; Cohort Studies; Comorbidity; Coronary Disease; Diabetes Mellitus; Female; Fibrinogen; Headache; Humans; Hypercholesterolemia; Hypertension; Income; Male; Middle Aged; Migraine with Aura; Migraine without Aura; Physical Exertion; Prevalence; Risk Factors; Sex Factors; Surveys and Questionnaires; United States; Vasoconstriction; White People | 2004 |
Fibrinolytic activity in Nigerian diabetics with renal insufficiency.
Topics: Adult; Aged; Blood Coagulation Tests; Creatinine; Diabetes Mellitus; Diabetic Nephropathies; Female; Fibrinogen; Fibrinolysis; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nigeria; Renal Insufficiency | 2005 |
Effect of antihypertensive treatment on plasma fibrinogen and serum HDL levels in patients with essential hypertension.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Glucose; Cholesterol, HDL; Creatine; Diabetes Mellitus; Female; Fibrinogen; Humans; Hypertension; Male; Middle Aged; Retrospective Studies; Smoking; Vascular Diseases | 2005 |
Optimistic for longevity.
Topics: Aged; Attitude; Biomarkers; Chronic Disease; Depression; Diabetes Mellitus; Fibrinogen; Happiness; Health Status; Heart Diseases; Humans; Hydrocortisone; Inflammation; Longevity; Middle Aged | 2005 |
Components of the metabolic syndrome and risk for first-ever acute ischemic nonembolic stroke in elderly subjects.
Topics: Aged; Apolipoprotein A-I; Brain Ischemia; Case-Control Studies; Cholesterol; Cholesterol, HDL; Diabetes Complications; Diabetes Mellitus; Female; Fibrinogen; Humans; Hypertension; Ischemia; Lipoprotein(a); Lipoproteins, HDL; Logistic Models; Male; Metabolic Syndrome; Obesity; Odds Ratio; Regression Analysis; Risk Factors; Stroke; Triglycerides; Uric Acid | 2005 |
Beta-fibrinogen haplotypes and the risk for cardiovascular disease in a dialysis cohort.
Topics: Adult; Aged; Alleles; Cardiovascular Diseases; Cohort Studies; Comorbidity; Diabetes Mellitus; Ethnicity; Female; Fibrinogen; Follow-Up Studies; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Inflammation; Kidney Failure, Chronic; Male; Middle Aged; Polymorphism, Genetic; Renal Dialysis; Risk; Smoking | 2005 |
[Explosion of cardiovascular risks in family practice].
Topics: Adolescent; Adult; Aged; Animals; Cardiovascular Diseases; Coronary Disease; Cross-Sectional Studies; Diabetes Mellitus; Diet; Erectile Dysfunction; Family Practice; Female; Fibrinogen; Fishes; Germany; Humans; Hyperlipidemias; Hypertension; Male; Meta-Analysis as Topic; Middle Aged; Prospective Studies; Risk Factors; Smoking | 2005 |
Glycaemic control influences peripheral blood flow and haemorheological variables in patients with diabetes mellitus.
Topics: Adult; Aged; Blood Viscosity; Diabetes Mellitus; Diabetic Foot; Female; Fibrinogen; Glycated Hemoglobin; Humans; Hyperglycemia; Male; Middle Aged; Regional Blood Flow | 2005 |
Full-mouth tooth extraction lowers systemic inflammatory and thrombotic markers of cardiovascular risk.
Topics: Adult; C-Reactive Protein; Cohort Studies; Diabetes Mellitus; Female; Fibrinogen; Follow-Up Studies; Heart Diseases; Humans; Hyperlipidemias; Hypertension; Inflammation Mediators; Leukocyte Count; Longitudinal Studies; Male; Middle Aged; Periodontitis; Plasminogen Activator Inhibitor 1; Platelet Count; Risk Factors; Smoking; Thrombosis; Tissue Plasminogen Activator; Tooth Extraction | 2006 |
Increased ability of tirofiban to maintain its inhibitory effects on the binding of fibrinogen to platelets in blood from patients with and without diabetes mellitus.
Topics: Aged; Diabetes Mellitus; Female; Fibrinogen; Flow Cytometry; Humans; In Vitro Techniques; Male; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine | 2006 |
Whole grains, bran, and germ in relation to homocysteine and markers of glycemic control, lipids, and inflammation 1.
Topics: Adult; Aged; Biomarkers; Blood Glucose; C-Reactive Protein; Cohort Studies; Cross-Sectional Studies; Diabetes Mellitus; Edible Grain; Female; Fibrinogen; Health Surveys; Heart Diseases; Homocysteine; Humans; Inflammation; Insulin; Interleukin-6; Leptin; Lipid Metabolism; Male; Middle Aged; Risk Factors | 2006 |
New International Diabetes Federation (IDF) and National Cholesterol Education Program Adult Treatment panel III (NCEP-ATPIII) criteria and the involvement of hemostasis and fibrinolysis in the metabolic syndrome.
Topics: Adult; Case-Control Studies; Cholesterol; Diabetes Mellitus; Female; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Male; Metabolic Syndrome; Obesity; Overweight; Patient Education as Topic; Plasminogen Activator Inhibitor 1; Societies; von Willebrand Factor | 2006 |
Risk factors for ischemic stroke subtypes: the Atherosclerosis Risk in Communities study.
Topics: Black or African American; Brain Ischemia; Comorbidity; Coronary Disease; Diabetes Mellitus; Educational Status; Female; Fibrinogen; Follow-Up Studies; Humans; Hypercholesterolemia; Hypertension; Hypertrophy, Left Ventricular; Incidence; Intracranial Embolism; Leukocyte Count; Lipoprotein(a); Male; Maryland; Middle Aged; Minnesota; Mississippi; Multivariate Analysis; North Carolina; Proportional Hazards Models; Prospective Studies; Risk Factors; Smoking; von Willebrand Factor; Waist-Hip Ratio; White People | 2006 |
Psychosocial factors and inflammation in the multi-ethnic study of atherosclerosis.
Topics: Aged; Aged, 80 and over; Atherosclerosis; Behavior; Biomarkers; Body Mass Index; C-Reactive Protein; Cross-Sectional Studies; Depression; Diabetes Mellitus; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Stress, Psychological; Trust | 2007 |
Insulin resistance is associated with circulating fibrinogen levels in nondiabetic patients receiving peritoneal dialysis.
Topics: Adult; Biomarkers; C-Reactive Protein; Cross-Sectional Studies; Diabetes Mellitus; Female; Fibrinogen; Humans; Insulin Resistance; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory | 2007 |
Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis.
Topics: Adiponectin; Adult; Blood Glucose; C-Reactive Protein; Cholesterol; Cystic Fibrosis; Diabetes Complications; Diabetes Mellitus; Female; Fibrinogen; Glucose Intolerance; Glucose Tolerance Test; Humans; Insulin; Lipoproteins, HDL; Male; Reference Values; Triglycerides | 2007 |
[Fibrinogens and their role in atherogenesis in diabetes mellitus].
Topics: Adult; Aged; Atherosclerosis; Coronary Thrombosis; Diabetes Mellitus; Female; Fibrinogen; Humans; Male; Middle Aged; Severity of Illness Index | 2007 |
Reverse glycoblotting allows rapid-enrichment glycoproteomics of biopharmaceuticals and disease-related biomarkers.
Topics: alpha-Fetoproteins; Amino Acid Sequence; Animals; Biomarkers; Biopharmaceutics; Diabetes Mellitus; Erythropoietin; Fibrinogen; Glycopeptides; Mice; Proteomics; Recombinant Proteins | 2007 |
Evidence that high von Willebrand factor and low ADAMTS-13 levels independently increase the risk of a non-fatal heart attack.
Topics: ADAM Proteins; ADAMTS13 Protein; Adult; Age Factors; Aged; Body Mass Index; C-Reactive Protein; Case-Control Studies; Cholesterol; Cholesterol, HDL; Diabetes Mellitus; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Risk; Risk Factors; Smoking; Triglycerides; von Willebrand Factor | 2008 |
Increased shear rate resistance and fastest kinetics of erythrocyte aggregation in diabetes measured with ultrasound.
Topics: Adult; Aged; Blood Pressure; C-Reactive Protein; Cholesterol; Diabetes Mellitus; Erythrocyte Aggregation; Erythrocytes; Fibrinogen; Glycated Hemoglobin; Humans; Immunoglobulin G; Kinetics; Male; Middle Aged; Shear Strength; Triglycerides; Ultrasonography | 2008 |
Blood fibrinolytic activity in non-pretreated diabetics and its changes caused by administration of sulfonylurea (tolbutamide).
Topics: Adult; Aged; Diabetes Mellitus; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Tolbutamide | 1967 |
Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy.
Topics: Adult; Age Factors; Aged; alpha-2-Antiplasmin; alpha-Macroglobulins; Antithrombin III; Arterial Occlusive Diseases; Blood Coagulation; Blood Coagulation Tests; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Factor VIII; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Thrombin Time | 1984 |
Microalbuminuria in diabetes.
Topics: Albuminuria; Blood Viscosity; Diabetes Mellitus; Fibrinogen | 1982 |
Antithrombin III activity and other coagulation changes in proliferative diabetic retinopathy.
Topics: Adult; Aged; alpha-Macroglobulins; Antithrombins; Diabetes Mellitus; Diabetic Retinopathy; Factor VIII; Female; Fibrinogen; Humans; Male; Middle Aged | 1980 |
Soluble fibrin complexes and fibrinogen heterogeneity in diabetes mellitus.
Topics: Adolescent; Adult; Aged; alpha 1-Antitrypsin; alpha-Macroglobulins; Antithrombin III; Blood Coagulation; Chromatography, Gel; Diabetes Mellitus; Diabetes Mellitus, Type 1; Disseminated Intravascular Coagulation; Electrophoresis, Polyacrylamide Gel; Female; Fibrin; Fibrinogen; Humans; Male; Middle Aged; Plasminogen; Solubility | 1980 |
Beta-thromboglobulin in diabetes: relationships with blood glucose and fibrinopeptide A.
Topics: Adolescent; Adult; Aged; Beta-Globulins; beta-Thromboglobulin; Blood Glucose; Diabetes Mellitus; Diabetic Angiopathies; Fibrinogen; Fibrinopeptide A; Humans; Middle Aged | 1981 |
Tests for platelet changes, acute phase reactants and serum lipids in diabetes mellitus and peripheral vascular disease.
Topics: Adult; Beta-Globulins; beta-Thromboglobulin; Bleeding Time; Cholesterol; Diabetes Mellitus; Diabetic Retinopathy; Factor VIII; Female; Fibrinogen; Humans; Intermittent Claudication; Lipids; Male; Middle Aged; Platelet Aggregation; Serotonin; Triglycerides | 1982 |
Factors involved in cell adhesion to vascular endothelium.
Topics: Anemia, Sickle Cell; Cell Adhesion; Cell Communication; Cells, Cultured; Culture Media; Diabetes Mellitus; Endothelium; Erythrocytes; Fibrinogen; Fibronectins; gamma-Globulins; Granulocytes; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Umbilical Veins | 1983 |
Nonenzymatic glycosylation reduces the susceptibility of fibrin to degradation by plasmin.
Topics: Binding Sites; Chemical Phenomena; Chemistry; Diabetes Mellitus; Fibrin; Fibrinogen; Fibrinolysin; Glucose; Humans; Hyperglycemia; In Vitro Techniques; Lysine; Protein Conformation; Time Factors | 1983 |
Acquired neutrophil myeloperoxidase deficiency: an indicator of subclinical activation of blood coagulation?
Topics: Adolescent; Adult; Aged; Blood Coagulation; Child; Child, Preschool; Diabetes Mellitus; Disseminated Intravascular Coagulation; Female; Fibrinogen; Humans; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutrophils; Peroxidase; Peroxidases; Thrombosis | 1983 |
Correlation of a clot-weight and radial immunodiffusion method for estimation of plasma fibrinogen concentration.
Topics: Adult; Aged; Blood Coagulation; Diabetes Mellitus; Female; Fibrinogen; Humans; Immunodiffusion; Middle Aged; Pregnancy | 1984 |
[Interrelation of diabetes mellitus, atherosclerosis and ischemic heart disease].
Topics: Adult; Aged; Arteriosclerosis; Cholesterol; Coronary Disease; Diabetes Complications; Diabetes Mellitus; Erythrocytes; Female; Fibrinogen; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Humans; Lipid Peroxides; Lipoproteins, HDL; Male; Middle Aged; Sterols | 1984 |
[Sterol-fibrinogen blood complexes in patients with diabetes mellitus and associated ischemic heart disease].
Topics: Adult; Aged; Coronary Disease; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Fibrinogen; Humans; Middle Aged; Sterols | 1983 |
Time course of reversibility of accelerated fibrinogen disappearance in diabetes mellitus: association with intravascular volume shifts.
Topics: Adolescent; Adult; Aged; Blood Coagulation Tests; Blood Pressure; Blood Volume; Diabetes Complications; Diabetes Mellitus; Erythrocyte Count; Female; Fibrinogen; Humans; Hyperglycemia; Iodine Radioisotopes; Kinetics; Male; Middle Aged | 1984 |
Changes of fibrinolysis and factor VIII coagulant, antigen, and ristocetin cofactor in diabetes mellitus and atherosclerosis.
Topics: Adult; Antigens; Arteriosclerosis; Cholesterol; Diabetes Complications; Diabetes Mellitus; Diabetic Retinopathy; Factor VIII; Fibrinogen; Fibrinolysis; Humans; Lipoproteins, HDL; Male; Middle Aged; Ristocetin | 1980 |
[Contact (prekallikrein) and fibrinolytic (plasminogen/antiplasmin value) system in the physiopathology of vascular complications of diabetes].
Topics: Adolescent; Adult; Aged; alpha-2-Antiplasmin; Antithrombin III; Diabetes Mellitus; Diabetic Angiopathies; Factor VIII; Fibrinogen; Fibrinolysis; Humans; Kallikreins; Middle Aged; Plasminogen; Prekallikrein | 1982 |
Fibrinogen, a modulator of erythrocyte adhesion to vascular endothelium.
Topics: Adult; Anemia, Sickle Cell; Cell Adhesion; Diabetes Mellitus; Endothelium; Erythrocytes; Female; Fibrinogen; Fibronectins; Glycated Hemoglobin; Hematocrit; Humans; Male; Middle Aged; Umbilical Veins | 1983 |
[Fibrinogen-bound sterols in diabetes mellitus patients].
Topics: Adult; Aged; Chronic Disease; Diabetes Mellitus; Fibrinogen; Humans; Middle Aged; Protein Binding; Sterols | 1983 |
[Hemostatis and protein glucosylation].
Topics: Adenosine Diphosphate; Blood Proteins; Diabetes Mellitus; Electrophoresis, Polyacrylamide Gel; Fibrinogen; Glucose; Glycated Hemoglobin; Humans; Platelet Aggregation; Protein Binding | 1983 |
Filterability and vascular disease--I. Red cell filterability in diabetes mellitus: its relation to other methods of measuring deformability and to blood viscosity.
Topics: Adult; Blood Glucose; Blood Viscosity; Diabetes Mellitus; Erythrocyte Membrane; Erythrocytes; Female; Fibrinogen; Hematocrit; Humans; Male; Micropore Filters; Middle Aged; Ultracentrifugation | 1981 |
A comparative study of fibrinolytic activity in normal versus diabetic human gingiva.
Topics: Adolescent; Adult; Diabetes Mellitus; Fibrin; Fibrinogen; Fibrinolysis; Gingiva; Humans; Periodontitis | 1980 |
Platelet adhesiveness, plasma fibrinogen, and fibrinolytic activity in juvenile-onset and maturity-onset diabetes mellitus.
Topics: Adolescent; Adult; Diabetes Mellitus; Diabetes Mellitus, Type 1; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Platelet Adhesiveness; Serum Globulins | 1981 |
Hemorheological characteristics of blood in various disease: diabetes mellitus, hypertension, acute infection, ischaemic heart disease & attempted suicide.
Topics: Blood Circulation; Blood Sedimentation; Blood Viscosity; Coronary Disease; Diabetes Mellitus; Erythrocytes; Fibrinogen; Hematocrit; Humans; Hypertension; Infections; Rheology; Stress, Mechanical; Suicide, Attempted | 1982 |
[Mechanisms responsible for hyperfibrinogenaemia in the diabetics ].
Topics: Adolescent; Adult; Age Factors; Aged; Child; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Retinopathy; Female; Fibrinogen; Glycated Hemoglobin; Humans; Male; Middle Aged | 1982 |
Improvements in the rheologic properties of blood induced by medium-term treatment with buflomedil in diabetic patients.
Topics: Adult; Aged; Blood Viscosity; Diabetes Mellitus; Erythrocytes; Fibrinogen; Hematocrit; Humans; Middle Aged; Pyrrolidines; Vasodilator Agents | 1982 |
Increased adhesion of erythrocytes to endothelial cells in diabetes mellitus and its relation to vascular complications.
Topics: Adult; Aged; Blood Vessels; Blood Viscosity; Cell Adhesion; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Endothelium; Erythrocytes; Female; Fibrinogen; Fibronectins; Humans; In Vitro Techniques; Male; Middle Aged; Plastics | 1981 |
Platelet adhesiveness, plasma fibrinogen and fibrinolytic activity in diabetes mellitus.
Topics: Adult; Blood Coagulation; Diabetes Mellitus; Fibrinogen; Humans; Middle Aged; Platelet Adhesiveness | 1981 |
Non-enzymatic glucosylation of fibrinogen.
Topics: Albumins; Binding Sites; Chromatography, Ion Exchange; Diabetes Mellitus; Fibrinogen; Glucose; Humans; Hydrogen-Ion Concentration; Thrombin Time; Urea | 1981 |
Fibrin (ogen) polymerization curve (FPC) in patients with "diabetes mellitus".
Topics: Antithrombin III; Diabetes Mellitus; Fibrinogen; Humans | 1981 |
Blood viscosity in young male diabetics with and without retinopathy.
Topics: Adolescent; Adult; Blood Viscosity; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Fibrinogen; Hematocrit; Humans; Male; Middle Aged | 1980 |
Distribution and correlates of insulin in elderly men. The Honolulu Heart Program.
Topics: Age Factors; Aged; Aged, 80 and over; Blood Glucose; Body Mass Index; Cholesterol, HDL; Diabetes Mellitus; Fasting; Fibrinogen; Hawaii; Heart Rate; Hematocrit; Humans; Hypertension; Insulin; Japan; Male; Obesity; Physical Exertion; Triglycerides; Vital Capacity | 1995 |
Blood coagulation and fibrinolysis in obese NIDDM patients.
Topics: Apolipoprotein A-I; Apolipoproteins B; Blood Coagulation; Blood Glucose; Body Mass Index; Body Weight; Cholesterol; Cholesterol, HDL; Diabetes Mellitus; Diabetes Mellitus, Type 2; Factor VII; Female; Fibrinogen; Fibrinolysis; Humans; Insulin; Lipoprotein(a); Male; Middle Aged; Obesity; Plasminogen; Reference Values; Tissue Plasminogen Activator; Triglycerides | 1994 |
Tissue plasminogen activator, its fast acting plasma inhibitor and protein C after renal transplantation.
Topics: Adolescent; Adult; Antigens; Diabetes Mellitus; Female; Fibrinogen; Humans; Kidney Transplantation; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Protein C; Time Factors; Tissue Plasminogen Activator | 1995 |
Prevalence of peripheral arterial occlusive disease and associated risk factors in a sample of southern Sardinian population.
Topics: Adult; Aged; Arterial Occlusive Diseases; Diabetes Mellitus; Female; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Italy; Male; Middle Aged; Obesity; Peripheral Vascular Diseases; Prevalence; Risk Factors; Smoking; Surveys and Questionnaires | 1994 |
Polymorphism in the promoter region of the beta-fibrinogen gene and fibrinogen plasma levels in an in-patient population.
Topics: Adult; Alleles; Diabetes Mellitus; Emergencies; Female; Fibrinogen; Genes; Genotype; Humans; Hypertension; Inpatients; Male; Middle Aged; Polymorphism, Genetic; Promoter Regions, Genetic; Sex Factors | 1994 |
Hypercoagulation in diabetes mellitus.
Topics: Adult; Blood Coagulation Disorders; Blood Glucose; Case-Control Studies; Diabetes Complications; Diabetes Mellitus; Female; Fibrinogen; Humans; Male; Middle Aged; Partial Thromboplastin Time; Prothrombin Time; Risk Factors | 1993 |
Ethnic differences in risk markers for heart disease in Bradford and implications for preventive strategies.
Topics: Adult; Aged; Alcohol Drinking; Asia; Cross-Sectional Studies; Diabetes Mellitus; England; Exercise; Fibrinogen; Humans; Hypertension; Lipids; Male; Middle Aged; Myocardial Ischemia; Risk Factors; Smoking | 1993 |
Moderate to high intensity conditioning leisure time physical activity and high cardiorespiratory fitness are associated with reduced plasma fibrinogen in eastern Finnish men.
Topics: Adult; Analgesics; Arthritis, Rheumatoid; Body Mass Index; Cerebrovascular Disorders; Coffee; Comorbidity; Coronary Disease; Diabetes Mellitus; Diet; Energy Metabolism; Exercise; Fibrinogen; Finland; Humans; Leisure Activities; Male; Middle Aged; Multivariate Analysis; Oxygen Consumption; Physical Fitness; Population Surveillance; Risk Factors; Smoking; Socioeconomic Factors | 1993 |
Measurement of non-enzymic glycosylation with a radiochemical assay.
Topics: Borohydrides; Chromatography, Affinity; Diabetes Mellitus; Electrophoresis, Polyacrylamide Gel; Fibrinogen; Glycoproteins; Glycosylation; Humans; Hydrolysis; Immunoglobulin G; NAD; Oxidation-Reduction; Radiochemistry; Serum Albumin | 1993 |
Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study.
Topics: Adult; Angina Pectoris; Cerebrovascular Disorders; Coronary Disease; Cross-Sectional Studies; Diabetes Mellitus; Family; Female; Fibrinogen; Heart Diseases; Humans; Hypertension; Intermittent Claudication; Male; Middle Aged; Myocardial Infarction; Risk Factors; Sex Factors | 1993 |
Hemostatic risk factors of coronary artery disease in the Chinese.
Topics: Adult; Aged; Aged, 80 and over; Antithrombin III; Blood Glucose; Case-Control Studies; China; Cholesterol; Coronary Angiography; Coronary Disease; Diabetes Mellitus; Factor VII; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Platelet Count; Risk Factors; Serine Proteinase Inhibitors; Taiwan; Triglycerides | 1995 |
Diabetes and coronary heart disease in American Indians: The Strong Heart Study.
Topics: Adult; Aged; Coronary Disease; Diabetes Mellitus; Female; Fibrinogen; Humans; Indians, North American; Lipoproteins; Male; Middle Aged; Nicotiana; Obesity; Odds Ratio; Plants, Toxic; Regression Analysis; Risk Factors; Smoking; Socioeconomic Factors | 1996 |
[Levels of tissue-type plasminogen activator (T-PA), its inhibitor (PAI-1) and fibrinogen in the blood of patients with type 1 and 2 diabetes mellitus].
Topics: Adult; Diabetes Mellitus; Fibrinogen; Humans; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator | 1996 |
Fibrinogen levels in women having coronary angiography.
Topics: Age Factors; Case-Control Studies; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus; Female; Fibrinogen; Humans; Logistic Models; Middle Aged; Risk Factors; Sex Factors; Smoking | 1996 |
Impaired glucose tolerance, diabetes, and cardiovascular disease risk factor profiles in the elderly. The Honolulu Heart Program.
Topics: Age Factors; Aged; Aged, 80 and over; Alcohol Drinking; Blood Glucose; Cardiovascular Diseases; Cholesterol; Cohort Studies; Cross-Sectional Studies; Diabetes Mellitus; Fibrinogen; Glucose Intolerance; Glucose Tolerance Test; Hawaii; Humans; Insulin; Male; Prevalence; Reference Values; Risk Factors; Smoking; Surveys and Questionnaires; Triglycerides | 1996 |
Regional differences in albuminuria among American Indians: an epidemic of renal disease.
Topics: Aged; Albuminuria; Arizona; Blood Glucose; Blood Pressure; Demography; Diabetes Mellitus; Disease Outbreaks; Female; Fibrinogen; Humans; Indians, North American; Kidney Diseases; Male; Middle Aged; Obesity; Oklahoma; Prevalence; Proteinuria; Risk Factors; South Dakota | 1996 |
Ticlopidine may reduce functional fibrinogen levels by inhibition of MPC incorporation into fibrin.
Topics: Diabetes Mellitus; Fibrin; Fibrinogen; Fibrinolytic Agents; Humans; Macromolecular Substances; Ticlopidine | 1997 |
Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis.
Topics: Aged; Arteriosclerosis; Blood Platelets; Bone Marrow; Coronary Disease; Diabetes Mellitus; Female; Fibrinogen; Flow Cytometry; Humans; Interleukin-6; Male; Megakaryocytes; Middle Aged; Ploidies | 1997 |
Activation of the fibrinolytic system in patients with coronary artery disease and hyperfibrinogenemia.
Topics: alpha-2-Antiplasmin; Blood Viscosity; Coronary Angiography; Coronary Thrombosis; Diabetes Mellitus; Erythrocyte Aggregation; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Hypercholesterolemia; Hypertension; Hypertriglyceridemia; Male; Middle Aged; Obesity; Plasminogen Inactivators; Regression Analysis; Risk Factors; Smoking; Tissue Plasminogen Activator | 1997 |
Plasma fibrinogen concentration in a Chinese population.
Topics: Adolescent; Adult; Aged; Asian People; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Female; Fibrinogen; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Male; Middle Aged; Prevalence; Risk Factors; Triglycerides | 1997 |
Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients.
Topics: Adult; Aged; Apolipoproteins B; Austria; Cholesterol, HDL; Comorbidity; Coronary Disease; Cross-Sectional Studies; Diabetes Mellitus; Female; Fibrinogen; Humans; Hypertension; Kidney Failure, Chronic; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Phenotype; Prevalence; Renal Dialysis; Risk Factors; Smoking | 1997 |
The apolipoprotein E and beta-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease.
Topics: Adult; Aged; Aged, 80 and over; Alleles; Apolipoprotein E4; Apolipoproteins E; Arteriosclerosis; Brain Ischemia; Cerebrovascular Disorders; Coronary Thrombosis; Diabetes Mellitus; Disease Susceptibility; Embolism; Female; Fibrinogen; Gene Frequency; Genotype; Germany; Humans; Hypercholesterolemia; Hypertension; Intracranial Embolism and Thrombosis; Ischemic Attack, Transient; Male; Middle Aged; Point Mutation; Polymorphism, Genetic; Risk Factors; Smoking | 1997 |
Plasma levels of nitrite/nitrate and platelet cGMP levels are decreased in patients with atrial fibrillation.
Topics: Aged; Atrial Fibrillation; beta-Thromboglobulin; Blood Platelets; Blood Proteins; Cerebrovascular Disorders; Comorbidity; Cyclic GMP; Diabetes Mellitus; Echocardiography; Female; Fibrinogen; Hemodynamics; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Myocardial Ischemia; Nitrates; Nitric Oxide; Nitrites; Risk Factors; Smoking; Thrombophilia | 1997 |
Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty.
Topics: Angioplasty, Balloon; Antithrombin III; Arterial Occlusive Diseases; Biomarkers; Blood Coagulation Tests; C-Reactive Protein; Cardiovascular Diseases; Comorbidity; Creatinine; Diabetes Mellitus; Female; Femoral Artery; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hyperlipidemias; Lipids; Male; Metabolic Clearance Rate; Peptide Fragments; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Popliteal Artery; Prospective Studies; Prothrombin; Recurrence; Risk; Risk Factors; Smoking; Thrombin; Thrombophilia; Tissue Plasminogen Activator; Treatment Failure; Ultrasonography, Doppler, Color; von Willebrand Factor | 1997 |
Apolipoprotein A, fibrinogen, age, and history of stroke are predictors of death in dialysed diabetic patients: a prospective study in 412 subjects.
Topics: Adult; Aged; Aging; Apolipoproteins A; Cause of Death; Cerebrovascular Disorders; Diabetes Mellitus; Female; Fibrinogen; Forecasting; Humans; Male; Medical Records; Middle Aged; Proportional Hazards Models; Prospective Studies; Renal Replacement Therapy; Survival Analysis; Vascular Diseases | 1997 |
Sex differences in coagulation and fibrinolysis in subjects with coronary artery disease.
Topics: Antigens; Arteriosclerosis; Blood Coagulation; Chest Pain; Comorbidity; Coronary Angiography; Coronary Disease; Diabetes Mellitus; England; Factor VII; Female; Fibrinogen; Fibrinolysis; Humans; Hypertension; Lipids; Male; Middle Aged; Obesity; Plasminogen Activator Inhibitor 1; Retrospective Studies; Risk Factors; Sex Factors; Smoking; von Willebrand Factor | 1998 |
Polymorphism of the platelet glycoprotein IIIa gene in patients with coronary stenosis.
Topics: Aged; Alcohol Drinking; Alleles; Angioplasty, Balloon, Coronary; Combined Modality Therapy; Comorbidity; Coronary Disease; Diabetes Mellitus; Female; Fibrinogen; Gene Frequency; Genotype; Humans; Hypertension; Lipids; Male; Middle Aged; Platelet Glycoprotein GPIIb-IIIa Complex; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Prevalence; Risk Factors; Smoking; Stents | 1998 |
[Comparative study of peripheral circulation, lipid metabolism and hemocoagulation in families with atherosclerosis and diabetes mellitus].
Topics: Adolescent; Adult; Aged; Arteriosclerosis; Blood Circulation; Blood Coagulation; Child; Cholesterol, HDL; Diabetes Mellitus; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Lipids; Male; Middle Aged; Triglycerides | 1998 |
Epidemiology of atherosclerotic peripheral arterial occlusive disease in Hong Kong.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Arteriosclerosis; China; Demography; Diabetes Mellitus; Female; Femoral Artery; Fibrinogen; Hong Kong; Humans; Hypercholesterolemia; Hyperglycemia; Hyperlipoproteinemias; Hypertension; Hypertriglyceridemia; Ischemia; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Peripheral Vascular Diseases; Popliteal Artery; Prevalence; Prospective Studies; Risk Factors; Sex Factors; Smoking | 1999 |
The relationship between fibrinogen and other coronary heart disease risk factors in a Chinese population.
Topics: Adult; Age Distribution; Aged; Analysis of Variance; Case-Control Studies; China; Comorbidity; Coronary Disease; Cross-Sectional Studies; Data Collection; Diabetes Mellitus; Female; Fibrinogen; Humans; Hypertension; Incidence; Linear Models; Male; Middle Aged; Obesity; Random Allocation; Risk Assessment; Risk Factors; Sampling Studies; Sex Distribution; Smoking | 1999 |
Association of the alpha-fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation.
Topics: Amino Acid Substitution; Atrial Fibrillation; Brain Ischemia; Comorbidity; Coronary Disease; Diabetes Mellitus; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Hypertension; Male; Point Mutation; Polymorphism, Genetic; Risk; Risk Factors; Smoking; Survival Analysis; Thromboembolism; Thrombophilia; Transglutaminases | 1999 |
Factor VIII and other hemostasis variables are related to incident diabetes in adults. The Atherosclerosis Risk in Communities (ARIC) Study.
Topics: Arteriosclerosis; Blood Coagulation Factors; Body Constitution; Body Mass Index; Cohort Studies; Diabetes Mellitus; Ethnicity; Factor VIII; Female; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Partial Thromboplastin Time; Risk Factors; Sex Factors; United States; von Willebrand Factor | 1999 |
The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction.
Topics: Animals; Blood Glucose; Cachexia; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Fibrinogen; Glycated Hemoglobin; Hepatomegaly; Hyperinsulinism; Islets of Langerhans; Lipids; Liver; Male; Mice; Mice, Inbred C57BL; Nicotinic Acids; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Risk Factors; Tetrahydronaphthalenes; Transcription Factors | 1999 |
Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.
Topics: Arteriosclerosis; Biomarkers; Blood Glucose; Blood Proteins; Brain Ischemia; Cohort Studies; Comorbidity; Diabetes Mellitus; Factor VIII; Female; Fibrinogen; Follow-Up Studies; Hemostasis; Humans; Incidence; Leukocyte Count; Lipids; Male; Middle Aged; Partial Thromboplastin Time; Platelet Count; Prospective Studies; Risk Factors; Texas; von Willebrand Factor | 1999 |
Determinants of population changes in fibrinogen and factor VII over 6 years: the Atherosclerosis Risk in Communities (ARIC) Study.
Topics: Aging; Arteriosclerosis; Cohort Studies; Diabetes Mellitus; Factor VII; Female; Fibrinogen; Humans; Longitudinal Studies; Male; Middle Aged; Population Surveillance; Prospective Studies; Risk Factors; Smoking | 2000 |
[Diabetes mellitus and fibrinogen. Hemorrheological and microcirculatory consequences].
Topics: Adult; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Erythrocyte Aggregation; Female; Fibrinogen; Hemorheology; Humans; Male; Microcirculation; Middle Aged | 2000 |
Hemorheologic variables in critical limb ischemia before and after infrainguinal reconstruction.
Topics: Aged; Aged, 80 and over; Blood Viscosity; Case-Control Studies; Diabetes Mellitus; Elbow; Erythrocyte Aggregation; Erythrocyte Deformability; Erythrocyte Volume; Female; Femoral Vein; Fibrinogen; Follow-Up Studies; Hemorheology; Humans; Intermittent Claudication; Ischemia; Leg; Male; Middle Aged; Plasma; Renal Insufficiency; Veins | 2000 |
[Significance of glycated fibrinogen measurements in diabetes mellitus].
Topics: Adult; Blood Glucose; Diabetes Mellitus; Female; Fibrinogen; Glycated Hemoglobin; Glycosylation; Humans; Male; Middle Aged | 1999 |
Effect of magnesium on fibrin formation from lower molecular weight (LMW) fibrinogen.
Topics: Blood Coagulation; Calcium; Case-Control Studies; Chemistry, Clinical; Diabetes Mellitus; Edetic Acid; Electrophoresis, Polyacrylamide Gel; Fibrin; Fibrinogen; Hemostasis; Humans; Ions; Magnesium; Models, Biological; Thrombin; Time Factors | 2000 |
The influence of persistent hyperglycaemia on hyperfibrinogenaemia and hyperviscosity in diabetes mellitus.
Topics: Adult; Aged; Blood Viscosity; Diabetes Mellitus; Female; Fibrinogen; Hemostasis; Humans; Hyperglycemia; Male; Middle Aged; Wound Healing | 2000 |
Hyperfibrinogenemia in patients of diabetes mellitus in relation to glycemic control and urinary albumin excretion rate.
Topics: Age Factors; Albuminuria; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Female; Fibrinogen; Humans; Male; Middle Aged; Risk Factors | 2001 |
Red blood cell aggregation measurements in whole blood and in fibrinogen solutions by different methods.
Topics: Adult; Blood; Blood Viscosity; Diabetes Mellitus; Erythrocyte Aggregation; Female; Fibrinogen; Hematologic Tests; Humans; Lasers; Male; Middle Aged; Myocardial Ischemia; Nephelometry and Turbidimetry; Optical Rotation; Solutions | 2001 |
Chlamydia pneumonia seropositivity correlates with serum fibrinogen and lipoprotein a levels: any role in atherosclerosis?
Topics: Aged; Antibodies, Bacterial; Arteriosclerosis; C-Reactive Protein; Cardiovascular Diseases; Carotid Artery Diseases; Chlamydophila pneumoniae; Cholesterol, LDL; Coronary Disease; Diabetes Complications; Diabetes Mellitus; Female; Fibrinogen; Humans; Immunoglobulin G; Lipoprotein(a); Male; Middle Aged; Risk Factors; Sex Factors; Triglycerides | 2001 |
Monitoring of cardiovascular risk factors in the diabetic clinics of an Italian region: the MOFRAD study.
Topics: Adult; Aged; Ambulatory Care Facilities; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Italy; Lipoproteins, HDL; Male; Middle Aged; Obesity; Risk Factors; Sex Characteristics; Smoking; Triglycerides | 2001 |
Impaired hemorheological properties in diabetic patients with lower limb arterial ischaemia.
Topics: Adult; Aged; Arteries; Blood Gas Monitoring, Transcutaneous; Blood Viscosity; Case-Control Studies; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Erythrocyte Aggregation; Female; Fibrinogen; Hemorheology; Humans; Hypoxia; Ischemia; Leg; Male; Middle Aged; Serum Albumin | 2001 |
The concomitant appearance of aggregated erythrocytes, leukocytes and platelets in the peripheral blood of patients with risk factors for atherothrombosis.
Topics: Aged; Arteriosclerosis; Cell Adhesion; Cell Aggregation; Cholesterol; Cholesterol, LDL; Cohort Studies; Comorbidity; Computer Systems; Diabetes Mellitus; Erythrocyte Aggregation; Female; Fibrinogen; Hemorheology; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Inflammation; Israel; Leukocyte Count; Leukocytes; Male; Middle Aged; Platelet Aggregation; Risk Factors; Smoking; Thrombophilia; Triglycerides | 2001 |
Rheological determinants of red blood cell aggregation in diabetic patients in relation to their metabolic control.
Topics: Acute-Phase Proteins; Blood Glucose; Blood Sedimentation; C-Reactive Protein; Cell Adhesion; Cell Aggregation; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Erythrocytes; Female; Fibrinogen; Hemorheology; Humans; In Vitro Techniques; Leukocyte Count; Male; Sensitivity and Specificity; Triglycerides | 2002 |
Impaired fibrinolytic compensation for hypercoagulability in obese patients with type 2 diabetes: association with increased plasminogen activator inhibitor-1.
Topics: Administration, Oral; Blood Coagulation; Body Mass Index; Cholesterol; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Hypoglycemic Agents; Male; Middle Aged; Obesity; Plasminogen Activator Inhibitor 1; Reference Values; Regression Analysis; Triglycerides | 2002 |
Markers of inflammation and hypercoagulability in diabetic and nondiabetic patients with lower extremity ischemia.
Topics: Aged; Biomarkers; Blood Coagulation Factors; Blood Proteins; Case-Control Studies; Diabetes Complications; Diabetes Mellitus; Female; Fibrinogen; Humans; Inflammation; Ischemia; Lower Extremity; Male; Thrombophilia | 2002 |
Diabetic retinopathy and the fibrinolytic system.
Topics: Age Factors; Aged; Alpha-Globulins; Blood Vessels; Chronic Disease; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Retinopathy; Enzyme Activation; Female; Fibrinogen; Fibrinolysis; Humans; Macroglobulins; Male; Obesity; Plasminogen; Time Factors | 1975 |
Blood changes in atherosclerosis and long after myocardial infarction and venous thrombosis.
Topics: alpha 1-Antitrypsin; alpha-Macroglobulins; Antithrombins; Arteriosclerosis; Blood Cell Count; Blood Coagulation; Blood Platelets; Diabetes Mellitus; Female; Fibrinogen; Follow-Up Studies; Hemostasis; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Platelet Factor 3; Platelet Factor 4; Sex Factors; Thrombophlebitis | 1975 |
Blood glycoprotein levels in diabetes mellitus.
Topics: alpha-Macroglobulins; Ceruloplasmin; Diabetes Mellitus; Diabetic Angiopathies; Fibrinogen; Glycoproteins; Haptoglobins; Humans; Lipoproteins, LDL | 1976 |
Treatment of severe diabetic hypertriglyceridaemia by plasma exchange.
Topics: Adult; Blood Viscosity; Cholesterol; Diabetes Mellitus; Female; Fibrinogen; Humans; Hyperlipidemias; Plasmapheresis; Triglycerides | 1978 |
Direct animal and indirect human evidence of altered platelet function in diabetics.
Topics: Adenosine Diphosphate; Adolescent; Adult; Aged; Animals; beta-Thromboglobulin; Blood Glucose; Blood Platelets; Blood Vessels; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Female; Fibrinogen; Humans; Insulin; Male; Middle Aged; Platelet Aggregation; Platelet Count; Prospective Studies; Prothrombin Time; Rabbits | 1979 |
Experimental and clinical evaluation of two "Atromid-S" analogues in relation to their differential modes of action.
Topics: Animals; Body Weight; Butyrates; Clofenapate; Clofibrate; Diabetes Mellitus; Fatty Acids, Nonesterified; Fibrinogen; Humans; Hyperlipidemias; Kinetics; Liver; Male; Organ Size; Rats; Receptors, Cell Surface; Serum Albumin; Species Specificity; Structure-Activity Relationship; Thyroxine-Binding Proteins | 1975 |
[Plasma fibrinogen activity in diabetes mellitus, hyperlipoproteinemia and hyperuricemia (author's transl)].
Topics: Adult; Aged; Blood Coagulation; Diabetes Mellitus; Female; Fibrinogen; Humans; Hyperlipidemias; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Triglycerides; Uric Acid; Vascular Diseases | 1976 |
Severe persistent biphasic local (immediate and late) skin reactions to insulin.
Topics: Aspergillus fumigatus; Biopsy; Complement C3; Diabetes Complications; Diabetes Mellitus; Female; Fibrinogen; Humans; Hypersensitivity; Immunoglobulins; Insulin; Insulin Antibodies; Middle Aged; Skin; Skin Tests | 1977 |
Reduced fibrinogen survival in diabetes mellitus. A reversible phenomenon.
Topics: Adult; Aged; Aspirin; Chromatography, DEAE-Cellulose; Chromatography, Gel; Diabetes Mellitus; Dipyridamole; Electrophoresis, Polyacrylamide Gel; Female; Fibrinogen; Heparin; Humans; Hyperglycemia; Male; Middle Aged; Time Factors | 1979 |
[Behavior of some indices of fibrinolysis (fibrinogen, FDP, plasminogen) in mature diabetics].
Topics: Adult; Diabetes Mellitus; Diabetic Angiopathies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Lipids; Male; Middle Aged; Plasminogen | 1979 |
Plasma fibrinogen in diabetes mellitus.
Topics: Adolescent; Adult; Age Factors; Aged; Biguanides; Diabetes Complications; Diabetes Mellitus; Diet, Diabetic; Female; Fibrinogen; Humans; Male; Middle Aged; Sulfonylurea Compounds | 1979 |
Changes of platelet function and blood clotting in diabetes mellitus.
Topics: Blood Coagulation; Blood Platelets; Chromatography, Gel; Diabetes Mellitus; Factor VIII; Fibrinogen; Humans; Malondialdehyde; Platelet Aggregation; Thromboxanes | 1979 |
Haemostatic variables associated with diabetes and its complications.
Topics: Adult; Blood Coagulation Factors; Diabetes Complications; Diabetes Mellitus; Diabetic Retinopathy; Female; Fibrinogen; Fibrinolysis; Humans; Insulin; Male; Middle Aged; Platelet Adhesiveness; Proteinuria | 1979 |
Diabetes control, fibrinogen, and hemoglobin A 1a-c.
Topics: Diabetes Mellitus; Diabetic Retinopathy; Fibrinogen; Hemoglobin A; Humans | 1978 |
The dilute whole blood clot lysis assay: a screening method for identifying postoperative patients with a high incidence of deep venous thrombosis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Blood Coagulation; Blood Coagulation Tests; Diabetes Mellitus; Female; Fibrinogen; Humans; Iodine Radioisotopes; Male; Middle Aged; Postoperative Complications; Thrombophlebitis; Time Factors | 1979 |
Fibrinogen content and fibrinolytic activity of blood in diabetics, before and after antidiabetic drugs.
Topics: Adolescent; Adult; Aged; Child; Diabetes Mellitus; Female; Fibrinogen; Fibrinolysis; Humans; Hypoglycemic Agents; Male; Middle Aged | 1977 |
Abnormal blood viscosity in diabetes mellitus and retinopathy.
Topics: Blood Viscosity; Diabetes Mellitus; Diabetic Retinopathy; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Regression Analysis | 1976 |
Metabolic influences in experimental thrombosis.
Topics: Animals; Blood Coagulation; Blood Platelets; Cholesterol; Diabetes Mellitus; Diet, Atherogenic; Fasting; Fatty Acids, Nonesterified; Fibrinogen; Kidney; Male; Obesity; Rats; Thrombophlebitis; Triglycerides | 1976 |
Determination of platelet and fibrinogen half-life with [75Se]selenomethionine: studies in normal and in diabetic subjects.
Topics: Adult; Blood Platelets; Diabetes Mellitus; Female; Fibrinogen; Half-Life; Humans; Male; Middle Aged; Selenium; Selenomethionine; Time Factors | 1975 |
Fibrinolysis in relation to circulation through the legs in diabetics.
Topics: Adult; Age Factors; Aged; Arteries; Blood Flow Velocity; Blood Pressure; Blood Vessels; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Retinopathy; Female; Fibrin; Fibrinogen; Fibrinolysis; Humans; Leg; Male; Middle Aged; Obesity; Plasminogen; Plethysmography, Impedance; Regional Blood Flow; Thrombophlebitis | 1975 |
Microrheology and light transmission of blood. III. The velocity of red cell aggregate formation.
Topics: Blood Viscosity; Cell Aggregation; Dextrans; Diabetes Mellitus; Erythrocytes; Female; Fibrinogen; Humans; Light; Motion Pictures; Multiple Myeloma; Photography; Photometry; Pregnancy; Rheology; Rotation | 1975 |
Red cell aggregation in blood flow. I. New methods of quantification.
Topics: Adolescent; Adult; Blood Flow Velocity; Blood Proteins; Diabetes Mellitus; Erythrocyte Aggregation; Fibrinogen; Humans; Middle Aged; Multiple Myeloma; Photometry; Rheology | 1976 |
Hyperfibrinogenemia. An important risk factor for vascular complications in diabetes.
Topics: Analysis of Variance; Blood Glucose; Cholesterol; Cholesterol, HDL; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Glycated Hemoglobin; Humans; Hypertension; Male; Middle Aged; Multivariate Analysis; Obesity; Reference Values; Risk Factors; Triglycerides | 1992 |
[Clinical significance of measuring glycated fibrinogen in plasma in diabetes mellitus].
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus; Diabetic Retinopathy; Fibrinogen; Humans; Middle Aged | 1992 |
Intravascular coagulation necrosis of the skin associated with cryofibrinogenemia, diabetes mellitus, and cardiolipin autoantibodies.
Topics: Aged; Autoantibodies; Blister; Cardiolipins; Cryoglobulins; Diabetes Complications; Diabetes Mellitus; Disseminated Intravascular Coagulation; Female; Fibrinogen; Fibrinogens, Abnormal; Humans; Necrosis; Risk Factors | 1991 |
The relative clotting activity of glycated and non-glycated forms of fibrinogen.
Topics: Blood Coagulation; Diabetes Mellitus; Fibrinogen; Humans | 1991 |
Haemorheology in diabetes.
Topics: Blood Viscosity; Diabetes Mellitus; Diabetic Angiopathies; Erythrocyte Deformability; Fibrinogen; Humans; Insulin; Rheology; Serum Globulins | 1990 |
Comparison of glycosylated fibrinogen, albumin, and haemoglobin as indices of blood glucose control in diabetic patients.
Topics: Adult; Biomarkers; Blood Glucose; Diabetes Mellitus; Female; Fibrinogen; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Middle Aged; Reference Values; Serum Albumin | 1990 |
The relationship between body weight and plasma viscosity in hypertensive diabetic Nigerians.
Topics: Blood Viscosity; Body Mass Index; Body Weight; Diabetes Complications; Diabetes Mellitus; Female; Fibrinogen; Humans; Hypertension; Male; Middle Aged | 1990 |
Social influences and cardiovascular risk factors as determinants of plasma fibrinogen concentration in a general population sample of middle aged men.
Topics: Body Mass Index; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Mellitus; Exercise; Family Characteristics; Fibrinogen; Humans; Leisure Activities; Male; Middle Aged; Risk Factors; Smoking; Social Class; Social Support; Socioeconomic Factors; Stress, Psychological; Sweden | 1990 |
[Assay of glycated fibrinogen in plasma as an indicator of blood glucose control].
Topics: Adult; Blood Glucose; Diabetes Mellitus; Female; Fibrinogen; Humans; Male; Methods; Middle Aged | 1990 |
Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience.
Topics: Aged; Arteriosclerosis; Blood Coagulation; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Female; Fibrinogen; Follow-Up Studies; Glucose; Glucose Tolerance Test; Humans; Incidence; Male; Middle Aged; Risk Factors | 1990 |
[Inhibitors of coagulation and fibrinolysis in diabetics].
Topics: Adult; alpha 1-Antitrypsin; alpha-Macroglobulins; Antithrombin III; Blood Coagulation; Diabetes Mellitus; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged | 1988 |
A study of platelet fibronectin immunofluorescence in peripheral vascular disease and diabetes mellitus.
Topics: Adult; Aged; Blood Platelets; Diabetes Mellitus; Fibrinogen; Fibronectins; Fluorescent Antibody Technique; Humans; Middle Aged; Platelet Aggregation; Staining and Labeling; Vascular Diseases | 1989 |
Glycated fibrinogen: a new index of short-term diabetic control.
Topics: Adult; Blood Glucose; Chromatography, Affinity; Cross-Sectional Studies; Diabetes Mellitus; Female; Fibrinogen; Humans; Hyperglycemia; Male; Middle Aged | 1989 |
Erythrocyte sedimentation rate in diabetic patients: relationship to glycosylated hemoglobin and serum proteins.
Topics: Adult; Aged; Blood Proteins; Blood Sedimentation; Diabetes Mellitus; Female; Fibrinogen; Glycated Hemoglobin; Humans; Male; Middle Aged; Serum Albumin | 1989 |
Release of prostacyclin after erythrocyte adhesion to cultured vascular endothelium.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Diphosphate; Adenosine Triphosphate; Adult; Anemia, Sickle Cell; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Blood Proteins; Blood Vessels; Cell Adhesion; Cells, Cultured; Cyclooxygenase Inhibitors; Diabetes Mellitus; Endothelium; Epoprostenol; Erythrocytes; Fibrinogen; Flurbiprofen; Humans; Leukocytes; Middle Aged; Plasma; Prostaglandins F; Thromboxane B2 | 1986 |
Plasma fibrinopeptide A levels during insulin-induced plasma glucose falls in diabetics.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus; Epinephrine; Female; Fibrinogen; Fibrinopeptide A; Growth Hormone; Humans; Insulin; Kinetics; Male; Middle Aged; Norepinephrine | 1987 |
[Fibrinopeptide A in patients with diabetes mellitus complicated by angiopathy].
Topics: Adult; Aged; Diabetes Complications; Diabetes Mellitus; Diabetic Retinopathy; Fibrinogen; Fibrinopeptide A; Humans; Middle Aged | 1986 |
Increased thromboplastic potential in diabetes: a multifactorial phenomenon.
Topics: Adult; Antithrombin III; Blood Coagulation Tests; Blood Glucose; Complement C1 Inactivator Proteins; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Fibrinogen; Humans; Platelet Aggregation; Thromboxane B2 | 1987 |
[Haptoglobin phenotype distribution in patients at high risk of developing myocardial infarct].
Topics: Adult; Aged; Blood Coagulation Tests; Diabetes Mellitus; Disease Susceptibility; Female; Fibrinogen; Haptoglobins; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Myocardial Infarction; Phenotype; Risk | 1985 |
The effects on lipids, blood viscosity and platelet aggregation of combined use of niceritrol (Perycit) and a low dose of acetylsalicylic acid.
Topics: Adult; Aged; Arteriosclerosis; Aspirin; Blood Viscosity; Diabetes Mellitus; Female; Fibrinogen; Humans; Hypertension; Lipids; Male; Middle Aged; Niceritrol; Nicotinic Acids; Platelet Aggregation | 1985 |
Fibrinopeptide-A in diabetes mellitus. Relation to levels of blood glucose, fibrinogen disappearance, and hemodynamic changes.
Topics: Adolescent; Adult; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Fibrinopeptide A; Glucose; Hemodynamics; Humans; Male; Middle Aged | 1985 |
Letter: Insulin and fibrinolytic activity.
Topics: Diabetes Mellitus; Fibrinogen; Fibrinolysis; Humans; Insulin; Lipoproteins | 1973 |
Localization of plasma proteins in small dermal blood vessels in diabetes. Preliminary report.
Topics: Adolescent; Adult; Aged; Albumins; Beta-Globulins; Blood Vessels; Child; Diabetes Mellitus; Female; Fibrinogen; Fluorescent Antibody Technique; gamma-Globulins; Humans; Male; Middle Aged; Skin | 1966 |
The effect of endogenous antibody on insulin-assay in the newborn infants of diabetic mothers.
Topics: Adult; Alpha-Globulins; Beta-Globulins; Blood Protein Electrophoresis; Chromatography; Diabetes Mellitus; Female; Fibrinogen; gamma-Globulins; Glucose; Humans; Immunoassay; Infant, Newborn; Insulin; Insulin Antibodies; Iodine Isotopes; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications; Protein Binding; Serum Albumin; Umbilical Cord | 1967 |
Experimental production of diabetes mellitus by a nonendocrinal approach.
Topics: Animals; Blood Coagulation; Blood Glucose; Diabetes Mellitus; Disease Models, Animal; Fibrinogen; Rabbits; Thrombin | 1974 |
Dynamic viscoelasticity of blood during clotting in health and disease.
Topics: Blood Cell Count; Blood Coagulation; Blood Platelets; Blood Sedimentation; Blood Viscosity; Diabetes Mellitus; Elasticity; Female; Fibrinogen; Hematocrit; Humans; Infections; Leukemia, Myeloid; Male; Neoplasms; Polycythemia Vera; Rheology; Thrombosis | 1973 |
Influence of ABO blood groups and fibrinogen on thrombus formation and aggregation of red cells in cardiovascular and malignant diseases: new aspects of biorheological characterization of disease.
Topics: ABO Blood-Group System; Blood Coagulation; Blood Sedimentation; Blood Viscosity; Cardiovascular Diseases; Cell Aggregation; Diabetes Mellitus; Erythrocytes; Fibrinogen; Graft Rejection; Hematocrit; Hemophilia A; Humans; Hyperthyroidism; Kidney Failure, Chronic; Kidney Transplantation; Melanoma; Myocardial Infarction; Prognosis; Rheology; Serum Albumin; Thrombosis; Transplantation, Homologous | 1973 |
Cryofibrinogenemia: incidence, clinical correlations, and a review of the literature.
Topics: Adolescent; Adult; Aged; Alcoholism; Blood Protein Disorders; Cryoglobulins; Diabetes Mellitus; Female; Fibrinogen; Humans; Hypertension; Leukocyte Count; Male; Middle Aged; Neoplasms; Poisoning; Thromboembolism; Thrombosis; Trypsin Inhibitors; Wounds and Injuries | 1972 |
Plasma thrombin clotting time and plasma fibrinogen in diabetes mellitus and atherosclerosis.
Topics: Adolescent; Adult; Aged; Arteriosclerosis; Blood Coagulation; Blood Coagulation Tests; Diabetes Mellitus; Fibrinogen; Glucose Tolerance Test; Heparin; Humans; Insulin; Middle Aged; Thrombin | 1972 |
[Role of plasma fibrinogen in diabetes mellitus].
Topics: Adolescent; Adult; Age Factors; Aged; Diabetes Mellitus; Diabetic Angiopathies; Female; Fibrinogen; Glucose Tolerance Test; Humans; Male; Middle Aged | 1972 |
[Fibrinogen-fibrin degradation products (FDP) in patients with various diseases].
Topics: Adolescent; Adult; Angina Pectoris; Chronic Disease; Diabetes Mellitus; Female; Fibrin; Fibrinogen; Hematologic Diseases; Humans; Kidney Diseases; Liver Diseases; Male; Middle Aged; Myocardial Infarction; Neoplasms | 1972 |
[Biochemical, physiopathological and clinical aspects of platelet adhesiveness].
Topics: Arteriosclerosis; Blood Coagulation; Blood Coagulation Disorders; Blood Platelet Disorders; Collagen; Diabetes Mellitus; Epinephrine; Fatty Acids; Fibrinogen; Humans; Liver Cirrhosis; Norepinephrine; Platelet Adhesiveness; Sarcoma; Serotonin; Thrombin; Trypsin; Uremia | 1972 |
Platelet and fibrinogen kinetic studies in diabetes mellitus.
Topics: Blood Platelets; Cell Survival; Diabetes Mellitus; Fibrinogen; Half-Life; Humans; Kinetics | 1973 |
Value of determination of F.D.P. during pregnancy by immunochemical and latex agglutination inhibition methods.
Topics: Diabetes Mellitus; Evaluation Studies as Topic; Female; Fibrin; Fibrinogen; Glycosuria; Humans; Immunoelectrophoresis; Latex Fixation Tests; Liver Diseases; Methods; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Urinary Tract Infections | 1974 |
Significant effect of ABO blood groups on the aggregation of red cells in patients with diabetes mellitus. Role of fibrinogen and serum proteins.
Topics: ABO Blood-Group System; Adult; Aged; Blood Proteins; Blood Sedimentation; Blood Viscosity; Diabetes Complications; Diabetes Mellitus; Erythrocytes; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Serum Albumin; Sex Factors | 1974 |
Pharmacological fibrinolysis in diabetes mellitus.
Topics: Blood Glucose; Diabetes Mellitus; Diabetic Angiopathies; Drug Interactions; Drug Therapy, Combination; Ethylestrenol; Female; Fibrinogen; Fibrinolysis; Humans; Male; Obesity; Phenformin; Thrombosis | 1974 |
[Viscosity of the blood, fibrinogen and hematocrit in diabetes mellitus].
Topics: Adult; Blood Proteins; Blood Viscosity; Cholesterol; Diabetes Mellitus; Female; Fibrinogen; Hematocrit; Humans; Lipids; Male; Middle Aged | 1972 |
Diabetes and atherosclerosis.
Topics: Adult; Age Factors; Aorta; Arteries; Arteriosclerosis; Autopsy; Cholesterol; Coronary Disease; Coronary Vessels; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Female; Fibrinogen; Humans; Insulin; Lipid Metabolism; Lipoproteins; Male; Middle Aged; Platelet Adhesiveness; Sex Factors; Thrombosis; Triglycerides | 1971 |
[Some indices of the blood coagulation system and thrombus-formation in patients with diabetes mellitus].
Topics: Adolescent; Adult; Aged; Arteriosclerosis; Blood Cell Count; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Factor XIII; Fibrinogen; Fibrinolysis; Heparin; Humans; Middle Aged; Prothrombin; Thrombelastography; Thrombin; Thrombosis | 1971 |
[Evaluation of euglobulin lysis time].
Topics: Arteriosclerosis; Blood Coagulation Tests; Diabetes Mellitus; Fibrinogen; Humans; Kidney Diseases; Serum Globulins; Uremia | 1971 |
Coagulability in diabetics.
Topics: Adolescent; Adult; Blood Coagulation; Blood Coagulation Tests; Calcification, Physiologic; Child; Child, Preschool; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Eye Manifestations; Factor V; Factor VII; Female; Fibrinogen; Heparin; Humans; Male; Methods; Middle Aged; Thrombin | 1967 |
Pharmacological enhancement and short-term stimulation of blood fibrinolytic activity.
Topics: Adolescent; Adult; Aged; Aminocaproates; Anticholesteremic Agents; Arteriosclerosis; Arthritis, Rheumatoid; Asthma; Clofibrate; Diabetes Mellitus; Female; Fibrinogen; Fibrinolysis; Humans; Hypoglycemic Agents; Immunoassay; Intermittent Claudication; Kidney Failure, Chronic; Liver Cirrhosis; Lung Neoplasms; Male; Metformin; Middle Aged; Neoplasm Metastasis; Nicotinic Acids; Phlebitis; Physical Exertion; Plasminogen; Primary Myelofibrosis; Propionates; Pulmonary Heart Disease; Testosterone; Tolazamide; Urea | 1969 |
Plasma fibrinogen: determination, normal values, physiopathologic shifts, and fluctuations.
Topics: Blood Coagulation; Blood Coagulation Disorders; Chemical Precipitation; Densitometry; Diabetes Mellitus; Fibrinogen; Glycine; Liver Diseases; Methods; Quaternary Ammonium Compounds; Sulfates; Ultraviolet Rays; Vascular Diseases | 1970 |
Platelet adhesiveness, plasma fibrinogen and factor 8 levels in diabetes mellitus.
Topics: Adolescent; Adult; Age Factors; Aged; Blood Glucose; Blood Platelets; Cataract; Child; Coronary Disease; Diabetes Complications; Diabetes Mellitus; Diabetic Retinopathy; Electrocardiography; Factor VIII; Fibrinogen; Humans; Hypertension; Lipids; Middle Aged; Platelet Adhesiveness; Sex Factors; Surface Properties; Vascular Diseases | 1970 |
Platelet aggregation and thrombus formation in Diabetes Mellitus: an in vitro study.
Topics: Adolescent; Adult; Aged; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Cell Aggregation; Child; Cholesterol; Diabetes Mellitus; Female; Fibrinogen; Humans; In Vitro Techniques; Male; Methods; Middle Aged | 1970 |
[Assay of fibrinolytic activity].
Topics: Arthritis, Rheumatoid; Clinical Laboratory Techniques; Diabetes Mellitus; Fibrinogen; Fibrinolysis; Gout; Hepatitis; Humans; Hypertension; Methods; Serum Globulins | 1970 |
Lipoprotein and fibrinogen studies in diabetes.
Topics: Adult; Aged; Capillary Fragility; Cholesterol; Diabetes Mellitus; Diabetic Angiopathies; Female; Fibrinogen; Humans; Lipoproteins; Male; Middle Aged; Triglycerides | 1971 |
[Studies on the relationship between serum cholesterol and plasma fibrinogen].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Cholesterol; Diabetes Mellitus; Dwarfism, Pituitary; Fatty Liver; Female; Fibrinogen; Humans; Hyperlipidemias; Male; Middle Aged; Nephrotic Syndrome; Obesity | 1968 |
The effects of phenphormin on blood fibrinolysis in diabetes mellitus.
Topics: Adolescent; Adult; Aged; Arteriosclerosis; Blood Glucose; Cholesterol; Diabetes Mellitus; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Phenformin; Time Factors | 1969 |
[Studies of the blood viscosity in diabetics].
Topics: Blood Proteins; Blood Viscosity; Diabetes Mellitus; Fibrinogen; Hematocrit; Humans; Middle Aged | 1969 |
Age and disease-related alterations in fibrinogen-euglobulin (fibrinolytic) behavior.
Topics: Adult; Aged; Aging; Blood; Diabetes Mellitus; Female; Fibrinogen; Fibrinolysis; Humans; Liver Cirrhosis; Male; Middle Aged; Serum Globulins | 1966 |